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Biomedical multimodal imaging approaches aim to improve the accuracy and effectiveness 
of current diagnosis by providing comprehensive disease information. With sharply increasing 
demands of functional imaging capability, several ultrasound-based state-of-the-art technologies 
have been developed to provide functional features of tissue, such as elastography to assess tissue 
mechanical property, thermal strain imaging to characterize tissue compositional property, and 
contrast-enhanced ultrasound imaging using microbubbles to assess blood perfusion, in addition 
to anatomical information provided by traditional grey-scale sonography. To further foster 
ultrasound imaging, in recent years photoacoustic imaging that detects optical contrast at relatively 
deep imaging depth has been developed. Photoacoustic imaging is capable providing non-invasive, 
real-time images of structural information with physiological features, such as oxygen saturation, 
representing hypoxia or the progression of cancer invasion and metastasis.  
In this thesis, the combined ultrasound and photoacoustic imaging approach is innovatively 
engineered to provide both structural and functional information in high spatio-temporal resolution 
and contrast. First, the light illumination scheme in photoacoustic imaging is reinvented. With a 
conventional photoacoustic imaging system, approximately 30% energy of excited light would be 
lost due to reflection on the skin surface. A new light delivery scheme can collect and re-distribute 
reflected light to recover such energy loss, leading to improved signal amplitude. Second, 
optically-triggered phase-transition droplets as a highly efficient photoacoustic contrast agent are 
developed. Their vaporization and recondensation dynamics are investigated by an innovative 
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 v 
approach of concurrent optical and acoustical measurements for better understanding of the 
underlying processes, which will eventually guide the design of repeatable phase-transition 
droplets. We also developed a novel photoacoustic dye with high photostability that allows for 
long time monitoring. Finally, in addition to photoacoustic imaging, deconvolution-based super-
resolution ultrasound imaging technology is developed to realize the spatial resolution beyond the 
acoustic diffraction limit, which enables to assess microvasculature with the sub-diffraction 
resolution, maintaining high temporal resolution. 
We envision that the developed novel imaging technologies will provide a strong 
motivation and a key technical foundation to build an ultrasound and photoacoustic multimodal 
imaging system, which will be useful in pre-clinical and clinical research in the future, and 
eventually translated into clinics. 
 
 vi 
TABLE OF CONTENTS 
1.0 INTRODUCTION ................................................................................................................. 1 
1.1 MULTIMODAL IMAGING TECHNIQUES .............................................. 1 
1.2 PHOTOACOUSTIC MOLECULAR IMAGING ........................................ 4 
1.3 SUPER-RESOLUTION ULTRASOUND IMAGING................................. 8 
1.4 LAYOUT OF THE THESIS ........................................................................ 10 
2.0 A LIGHT ILLUMINATION ENHANCEMENT DEVICE FOR PHOTOACOUSTIC 
IMAGING: IN VIVO ANIMAL STUDY .......................................................................... 12 
2.1 INTRODUCTION......................................................................................... 13 
2.2 MATERIALS AND METHODS ................................................................. 15 
2.2.1 Photoacoustic imaging ................................................................................... 15 
2.2.2 The light catcher: a prototype manufacturing............................................ 15 
2.2.3 Experiment setup of PA imaging ................................................................. 17 
2.2.4 Photoacoustic contrast agents....................................................................... 19 
2.2.5 Ex vivo experiment using chicken breast tissues ........................................ 20 
2.2.6 In vivo experiment using mouse tumor model ............................................ 22 
2.3 RESULTS AND DISCUSSIONS ................................................................. 23 
2.3.1 Ex vivo study: Light delivery enhancement with the light catcher in chicken 
breast tissues .................................................................................................. 23 
2.3.2 In vivo study: PA signal enhancement with the light catcher in mouse 
tumor model .................................................................................................. 26 
2.4 CONCLUSION ............................................................................................. 29 
 vii 
2.5 ACKNOWLEDGEMENTS ......................................................................... 29 
3.0 VAPORIZATION AND RECONDENSATION DYNAMUCS OF INDOCYANINE 
GREEN-LOADED PERFLUOROPENTANE DROPLETS IRRADIATED BY A 
SHORT PULSE LASER ..................................................................................................... 30 
3.1 INTRODUCTION......................................................................................... 31 
3.2 MATERIALS AND METHODS ................................................................. 32 
3.2.1 Synthesis of PFC droplet ............................................................................... 32 
3.2.2 Experiment setup ........................................................................................... 34 
3.3 RESULTS AND DISCUSSIONS ................................................................. 36 
3.4 CONCLUSIONS ........................................................................................... 42 
4.0 PHOTOSTABLE, HYDROPHILIC, AND NEAR INFRARED QUATERRYLENE-
BASED DYES FOR PHOTOACOUSTIC IMAGING .................................................... 44 
4.1 INTRODUCTION......................................................................................... 45 
4.2 MATERIALS AND METHODS ................................................................. 47 
4.2.1 Materials: Synthesis of QR-4PyC4 and QR-G2-COOH ............................ 47 
4.2.2 Cell culture of MDA-MB-231 ....................................................................... 49 
4.2.3 Cytotoxicity evaluation of QR-4PyC4.......................................................... 49 
4.2.4 Cellular uptake study .................................................................................... 50 
4.2.5 Photoacoustic imaging and bright-field imaging ........................................ 51 
4.3 RESULTS AND DISCUSSIONS ................................................................. 52 
4.3.1 Dendrimer characterization ......................................................................... 52 
4.3.2 Photostability evaluation ............................................................................... 55 
4.3.3 Cellular uptake and viability test ................................................................. 55 
 viii 
4.3.4 Photoacoustic imaging of MDA-MB-231 using QR-4PyC4, QR-G2-COOH, 
and ICG.......................................................................................................... 57 
4.4 CONCLUSION ............................................................................................. 60 
4.5 ACKNOWLEDGEMENTS ......................................................................... 61 
5.0 SUPER-RESOLUTION ULTRASOUND IMAGING WITH HIGH TEMPORAL 
RESOLUTION: IN VIVO FEASIBILITY ON VASA VASOROM IN 
ATHEROSCLEROSIS RABBIT MODEL ....................................................................... 62 
5.1 INTRODUCTION......................................................................................... 63 
5.2 MATERIALS AND METHODS ................................................................. 66 
5.2.1 Deconvolution-based super-resolution US imaging sequence ................... 66 
5.2.2 Spatio-Temporal-Interframe-Correlation (STIC) based data re-alignment 
algorithm ........................................................................................................ 69 
5.2.3 Rabbit atherosclerotic plaque model ........................................................... 71 
5.2.4 Ultrasound imaging protocol ........................................................................ 72 
5.2.5 Histology and Immunofluorescence ............................................................. 73 
5.3 RESULS AND DISCUSSIONS .................................................................... 74 
5.3.1 Deconvolution based super-resolution ultrasound imaging ...................... 74 
5.3.2 In vivo feasibility of the developed super-resolution technique in imaging 
vasa vasorum on a rabbit femoral artery ................................................... 77 
5.4 CONCLUSION ............................................................................................. 80 
5.5 ACKNOWLEDGEMENTS ......................................................................... 81 
6.0 CONCLUSIONS .................................................................................................................. 82 
APPENDIX A .............................................................................................................................. 84 
 ix 
APPENDIX B .............................................................................................................................. 87 
APPENDIX C .............................................................................................................................. 90 
BIBLIOGRAPHY ..................................................................................................................... 101 
 x 
LIST OF TABLES 
Table 1. In vivo experiment results: The normalized and averaged PA signal amplitude (a.u.) in 
the ROI and enhancement ratio when using the light catcher. ........................................ 28 
Table 2. The photophysical properties of ICG, QR-G2-COOH and QR-4PyC4 at 10 μM PBS 
solution. ........................................................................................................................... 54 
 xi 
LIST OF FIGURES 
Figure 1. Cumulative percentage ratio of people diagnosed at each stage. (American cancer 
society, 2015) ................................................................................................................. 2 
Figure 2. Hybrid imaging system based on US imaging technologies and potential applications. 3 
Figure 3. Scalability and tradeoff between imaging depth and spatial resolution in different 
configuration of PA imaging systems [34]. .................................................................... 6 
Figure 4. The developed high-frequency ultrasound transducer integrated with the light catcher for 
PA imaging. (a, b) 3D drawing of the light catcher prototype. All parts were fabricated 
using 3D printing technology. (a,d) The handheld style housing was made for freehand 
scanning. (b,c,e) The detailed configurations of the ultrasound transducer and bifurcated 
optical fiber bundle integrated with the light reflecting mirrors. The angle between the 
transducer and the optical fiber is 30°. The concave shape light catcher is 12.7 mm in 
height and 25.4 mm in diameter. The light catcher inner surface was coated with silver. 
(f) For experimental evaluation of the device under the same geometrical setups of the 
optical fiber and the ultrasound transducer, two types of insertion with and without the 
light reflecting mirror were built. UT: Ultrasound transducer; w/ LC: with the light 
catcher; w/o LC: without the light catcher ................................................................... 16 
Figure 5 (a) Experimental setups for ex vivo tissue and in vivo animal study. A commercial 
research ultrasound scanner was synchronized with a tunable laser system. A short laser 
pulse of 5 ns long was delivered through a bifurcated optical fiber attached to both sides 
of the US transducer. The concave reflecting mirror of the light catcher was placed on 
the target covered with ultrasound gel. (b) Laser fluence was measured at different 
 xii 
depths (5, 10, and 15 mm) in chicken breast tissues (thickness of each tissue slab: 5 mm) 
at 689 and 800 nm (c) PA signal was measured from a polyethylene tube (Inner 
diameter: 580 μm, Outer diameter: 965 μm) filled with a contrast agent that was placed 
between chicken breast tissues of varying thickness. (d) For in vivo animal study, a 
contrast agent was locally injected into a subcutaneous tumor (Diameter: 1 cm) on the 
back of a mouse. ........................................................................................................... 18 
Figure 6. Normalized absorption spectrums of the verteporfin solution (a) and the ICG solution at 
65 μM (b). In addition to its major absorption peak at the visible light at nearby 430 nm 
(Blue light), a distinct secondary absorption peak of verteporfin in the NIR at 800 nm.
 ...................................................................................................................................... 20 
Figure 7. Ex vivo experiment results: Measured laser energy at 689 nm (a) and 800 nm (b) at 
different depths in chicken breast tissues. Laser energy is measured at 5, 10, and 15 mm 
depth of chicken breast tissues with (white) and without (black) the light catcher. Each 
bar represents the mean of laser energy over 50 measurements with an error bar of the 
standard deviation. w/o LC: without the light catcher; w/ LC: with the light catcher. 24 
Figure 8. Ex vivo experiment results: Short-axis PA images from a tube filled with (a) verteporfin 
taken at 689 nm and (b) ICG taken at 800 nm that was embedded in chicken breast tissue 
at depth of 15 mm. The left panels are for the case without using the light catcher and 
the right panels are for the case when using the light catcher. White dotted circles 
represent a polyethylene tube. (c) PA signal was enhanced by 37.6% for verteporfin at 
689 nm and by 32.5% for ICG at 800 nm. ................................................................... 25 
Figure 9. In vivo experiment results: Normalized PA images with and without the light catcher. 
(a) PA image overlaid on ultrasound B-mode image with 40 dB log-compression. The 
 xiii 
yellow dashed contour represents the tumor location of the mouse and the top layer of 
the tumor is skin with hair removed. The white dashed box (Height: 1.2 mm, Width: 2.0 
mm) indicates the region of interest (ROI) where the photosensitizer is administered. (b) 
PA images of ROI when using (Lower row) and without using the light catcher (Upper 
row) for each mouse (n = 8) within a depth of 14.6-15.8 mm. All PA images are 
normalized by measured laser fluence and shown in same dynamic range. (c) Statistical 
analysis of in vivo study results (Table 1). Solid circles and triangles represent averaged 
PA signal amplitudes in ROI with and without the light catcher, respectively. The central 
line of the boxplot is median, the edges of the box are 25th and 75th percentiles, and 
two whiskers above and below of the box are the maximum and the minimum of 
measurements. .............................................................................................................. 27 
Figure 10. Schematic of the ICG-loaded PFP droplets (a); Confocal fluorescent microscopy image 
of a droplet (b) before vaporization (Left panel) and after vaporization (Right panel).
 ...................................................................................................................................... 33 
Figure 11. Experiment schematic. A high-speed optical microscopy apparatus equipped with a 
water immersion objective lens (60×) was combined with NIR laser for PA excitation. 
Short pulse laser of 5 ns duration tuned at 800 nm was illuminated onto the target though 
the objective lens. Acoustic signal from vaporization was captured by a single element 
focused ultrasound transducer. Green and red arrows represent the light paths of the 
excitation laser for vaporization and white light for brigthfield imaging, respectively. 
Acoustic and optical systems were aligned on the focal plane of the sample and 
synchronized through a custom-made FPGA-based timing controller. T/R: 
Transmitter/Receiver, OSC: oscilloscope. ................................................................... 35 
 xiv 
Figure 12. Selected frames of high-speed imaging at 5 million frames per second (a, d) and acoustic 
signal measurement (Red solid line in (c, f)) and theoretical estimation (Blue solid line 
in (c, f)) from shell dynamics of a large droplet (Diameter = 4.8 μm, (a-c)) and a small 
droplet (Diameter = 2.0 μm, (d-f)) with short pulse laser excitation. (5 ns duration, 800 
nm wavelength). Laser was excited at 0 μs. Analytic pressure calculation was performed 
using Eq. 2 with radius-time curves (b, e) measured by high-speed optical imaging. . 37 
Figure 13. Repeatability of vaporization-recondensation and stability of droplet. (a) Optical (top 
panels) and acoustical (bottom panels) observations over 6 laser excitations on the same 
droplet measuring 2.0 μm in diameter at baseline. The envelopes of PA pressure were 
measured from multiple ODV processes of the same single droplet and corresponding 
high-speed images of each vaporization are shown in the top panel. Far left and far right 
panels depict droplets initially and 1 hour later, respectively. (b) Optical recording of a 
larger droplet (7.7 μm baseline diameter) over 1 second, imaged at lower frame rate. 
The vaporized droplet continually expanded after vaporization, and then floated away 
at 1 second. ................................................................................................................... 39 
Figure 14. Laser-induced vaporization of various sized droplets at different ambient temperatures. 
The snapshots at three different time points of 0.2 µs before laser excitation (left 
column), 0.6 µs after laser excitation (center column) and 2 µs after laser excitation 
(right column) during vaporization-recondensation processes below the bulk boiling 
temperature (20°C, top two rows) of PFP and above boiling temperature (37°C, bottom 
two rows) are depicted. Note that a laser pulse of 5 ns-long was induced at time 0 s over 
the circled area in green as shown in the left column. The dotted white circle identifies 
the droplet of interest located at the center of laser beam. The relatively large droplet 
 xv 
(diameter of 7.9 µm) in a medium with temperature above the bulk boiling temperature 
of PFP did not recondense after vaporization. ............................................................. 40 
Figure 15. Summary of observation and interpretation of experimental results. Each solid circle 
represents a measurement condition (n = 3, data binned with ± 0.5 µm). Recondensation 
was observed in blue colored droplets, and not observed in red colored droplets. Note 
each circle was scaled to the initial droplet size. *These droplets grew continually into 
a large gas bubble at later time. A droplet can be placed in three different states: (1) 
Vaporized (gas) or superheated state (liquid, light-red region), (2) Quasi-superheated 
state (liquid, light-blue or light-purple region), (3) liquid state (light-green region). The 
solid curve represents the size-dependent estimated boiling points of droplets as a 
reference threshold for vaporization. The dotted curve indicates the initial size of the 
droplets at each given temperature that can reach to the size on the solid curve at the 
same temperature after vaporization. Therefore, the droplets below the dotted curve will 
likely recondense, while those above will likely not reconsense after vaporization. ... 41 
Figure 16. (a) Chemical structure of QR-G2-COOH; (b) The precursor QR-4Py and the synthetic 
route of QR-4PyC4 ....................................................................................................... 48 
Figure 17 Acoustic-resolution photoacoustic microscopy setup for cell study. UT: Single element 
focused ultrasound transducer (f0 = 30 MHz) .............................................................. 51 
Figure 18 Optical characteristic and photoacoustic response of QR-4PyC4, QR-G2-COOH, and 
ICG dyes. (a) Absorption spectrums of QR-4PyC4 (blue solid line), QR-G2-COOH 
(black solid line), and ICG (red solid line) in PBS solution at 10 µM concentration. (b) 
Change of PA signal amplitude at 740 nm of QR-4PyC4 (blue solid line), QR-G2-
COOH (black solid line), and ICG (red solid line) over 3,600 short-pulse laser 
 xvi 
exposures. Each data point represents an average over 5 measurements and error-bars 
are shown every 60 points. ........................................................................................... 53 
Figure 19. Fluorescence spectra of ICG, QR-G2-COOH and QR-4PyC4 at 10 µM .................... 54 
Figure 20. Cellular uptake percentage of QR-4PyC4, G2-QR-COOH, and ICG dyes. ................ 56 
Figure 21. Cell viability of QR-4PyC4 in MDA-MB-231 cells. Cell medium (Dye concentration 
at 0 μM) was used as a negative control, non-toxic, and, Doxorubicin (DOX) was used 
as a positive control, toxic. ........................................................................................... 56 
Figure 22. (a) Optical microscopy image (10x) and (b) Photoacoustic image of MDA-MB-231 
cells with QR-4PyC4 dye overlaid on microscopy image. Cells are marked as green 
spots. PA signal intensity is directly proportional to cell confluence. ......................... 57 
Figure 23. Photoacoustic image of MDA-MB-231 cells stained with QR-4PyC4, QR-G2-COOH, 
and ICG. Images in each column are subsequently acquired. ...................................... 58 
Figure 24. Averaged PA signal amplitudes of MDA-MB-231 cells stained with QR-4PyC4, QR-
G2-COOH, and ICG. .................................................................................................... 59 
Figure 25. Block diagram for signal processing of super-resolution ultrasound imaging. BF: Delay-
and-sum beamformer; QD: Quadrature demodulator; CF: Eigen-based spatio-temoral 
clutter filter; ED: Envelope detector; DV: Deconvolution with the system PSF; ∑: 
Integrator with STIC data alignment based on estimated cardiac pulsation. ............... 66 
Figure 26. Conceptual demonstration of sub-wavelength localization using deconvolution on 
synthetic data. (a) PSF of imaging system. FWHM is assumed as 150 µm. (b) The 
locations of the two neighboring targets. Two targets are positioned 70 µm apart. (c) 
Synthetic signal received from two targets is shown in (b) using the imaging system 
with PSF shown in (a). Two targets cannot be separated in the image due to their distance 
 xvii 
is shorter than the spatial resolution of imaging system. (d) Deconvolution results of 
received signal shown in (c) using the system PSF shown in (a). Two targets are 
distinctly identified. (e) Synthetic signal received from two targets when noise is added 
is shown in (b) using the same imaging system. (f) Deconvolution results of (e), where 
two targets are clearly identified with minimal interference due to noise ................... 68 
Figure 27. Estimated cardiac pulsation by counting the numbers of flowing microbubbles (blue 
solid line). After applying low-pass-filtering, the frames with minimum value are chosen 
as reference frames for synchronization (red solid line) .............................................. 70 
Figure 28. Graphical diagram of STIC data acquisition. Sequentially acquired multiple datasets 
are synchronized to form single cardiac cycle event based on the cardiac pulsation 
estimated by the numbers of bubbles. .......................................................................... 71 
Figure 29. Experiment setup of rabbit imaging. Microbubbles were injected via ear vein access. A 
hockey stick linear array ultrasound transducer was used for imaging. Transducer holder 
is used to remove operator-dependent motion in this study ......................................... 73 
Figure 30. Comparison of several imaging modalities. (a) CadenceTR contrast enhanced imaging 
with microbubbles acquired by commercial ultrasound scanner (Sequoia 512, Siemens), 
(b) conventional B-mode imaging, (c) temporal MIP vascular imaging, (d) proposed 
super resolution imaging of ROI. Same raw data is used to reconstruct images (b-d). 
White rectangle represents balloon injured area that the plaque is expected to be 
developed. White arrow indicates the same vessel branch that shows correlation of 
images acquired by two different ultrasound scanners. ............................................... 75 
 xviii 
Figure 31. Spatial resolution of proposed imaging method. (a) One of the finest vessels is chosen 
(white solid line) in the ROI, (b) Spatial profile of selected vessel. FWHM is estimated 
by 41 μm (<λ/5). ........................................................................................................... 76 
Figure 32. Repeatability of proposed method. (a) temporal MIP vascular network imaging using 
eigen-decomposition method. (b-d) Super-resolution images using sequentially 
acquired three datasets (2,000 frames per each image) from same region of interest. . 77 
Figure 33. B-mode image (a, d) and corresponding super-resolution perfusion image overlaid on 
the B-mode image at diastole (b, e) and systole state (c, f). Top panel images are acquired 
from the injured side and bottom panel images are acquired from the non-injured side. 
Significant plaques are shown in the B-mode image on the injured side. Yellow dotted 
line represents adventitia region and white arrows indicate vasa vasorum in the 
adventitia ...................................................................................................................... 78 
Figure 34. Haematoxylin and eosin stained vessel on the injured side (a) and non-injured side (b). 
Thirty images acquired at ×40 magnification are stitched to reconstruct overall image of 
the vessel for (a) and (b). Significant plaque development is found in injured side (a). 
Vasa vasorum on adventitia in selected region was stained by anti-von Willebrand 
factor. A large number of vasa vasorums are found in adventitia on the injured side (c), 
but a few vasa vasorums are found in adventitia on the non-injured side (d). ............. 79 
Figure 35. Vaporization threshold temperature according to droplet diameter ............................ 87 
Figure 36. Theoretical expansion ratio vs droplet diameter ......................................................... 89 
Figure 37. Timing diagram for the laser system and the high-speed camera ............................... 90 
Figure 38. Block diagram of the interface between FPGA, the high-speed camera, and the laser 
system. .......................................................................................................................... 92 
 xix 
Figure 39. Timing diagram of flash-lamp and Q-switch of the laser system ............................... 93 
Figure 40. Scenarios for capture success and failure .................................................................... 94 
Figure 41. Developed timing controller using FPGA board with add-on input/output circuit ..... 96 
 xx 
PREFACE 
This thesis is dedicated to 
all my advisors,  
all my colleagues, 
all my friends, 
 
and 
 
Love, my family. 
Thank you all for your unwavering support. 
 
 
 1 
1.0  INTRODUCTION 
1.1 MULTIMODAL IMAGING TECHNIQUES 
Cancer is a leading cause of death worldwide that accounts for 8.2 million deaths in 2012 
according to the recent published statistics by World Health Organization (WHO) in 2015 [1]. 
Successful therapeutic strategies to combat cancer require a thorough understanding of the 
structural, metabolic and functional properties of the disease. Therefore, gathering such 
multifaceted information via a multi-modal approach is highly sought after to improve staging, 
treating, and managing cancer as well as to increase the likelihood of early detection of cancer [2]. 
Figure 1 clearly shows the importance of early detection of cancer for significantly increased 
survival rate. The critical need of accurate characterization of cancer for early detection using 
multiple functional features of cancerous tissue has motivated extensive development of various 
biomedical imaging modalities. Ultrasound (US) imaging, magnetic resonance imaging (MRI), 
computed tomography (CT), positron emission tomography (PET), and single photon emission 
computed tomography (SPECT) are established stand-alone imaging modalities to screen or 
diagnose cancer in the clinic [3]. Some clinical imaging systems have been used with limitations 
such as safety issues such as ionizing radiation (CT) or use of nuclear medicine (PET/SPECT), or 
the relatively low temporal and spatial resolution and the financial burden placed on patients  and 
healthcare system (MRI) [3].  
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Figure 1. Cumulative percentage ratio of people diagnosed at each stage. (American cancer society, 2015) 
 
Despite its inherent limitations with operator dependency and limited imaging view etc., US 
imaging is a widely-favored medical imaging technology of patient and physician for its safety 
(non-ionizing/non-invasive), ease-of-use, the anatomical/functional information provided in real-
time, and affordability. Furthermore, accuracy of disease diagnosis can be improved by using 
multi-modes in a US imaging system, such as the Doppler technique, three-dimensional imaging, 
contrast-enhanced imaging with gas-filled microbubbles, thermal strain imaging, shear-wave 
elastography, and photoacoustic (PA) imaging [4]–[15]. Figure 2 illustrates the concept of hybrid 
US imaging system implemented with four independent but related imaging technologies for 
improved disease diagnosis that is capable of assessing structural and morphological information 
via conventional grayscale sonography, mechanical property via elasticity imaging (e.g., softness 
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of the tissue that correlated with the lipid rich necrotic core in atherosclerotic plaque [16]), 
compositional property via thermal strain imaging (e.g., fat component of fatty liver [17] or 
enriched lipid core in atherosclerotic plaque [18]), and biological characteristics via PA imaging 
of the lesion (e.g., optical contrast from dyed engineered tissue [19]). 
 
 
Figure 2. Hybrid imaging system based on US imaging technologies and potential applications. 
 
Among these approaches, laser-induced ultrasonography, also known as photoacoustic (PA) 
imaging, has been extensively developed in the past decade to provide unique functional imaging 
based on strong optical contrast at ultrasonic imaging depth and spatial resolution [20]–[26]. 
Endogenous optical contrasts can provide valuable functional information regarding angiogenesis, 
hypoxia (deficiency in the amount of oxygen reaching the tissues), invasion and metastasis that 
are important indicators for cancer diagnosis [27]–[30]. Note that optical contrasts have only been 
provided by optical imaging techniques such as microscopes, fluorescence, and bioluminescence 
 4 
at a depth of below a few millimeters or projected information with no depth information  [26].  In 
pre-clinical studies, PA imaging has shown promising results in tumor characterization using 
multiple types of information, such as location, microvascular network, blood flow and oxygen 
saturation [21]–[26]. In addition, PA imaging has the potential to be patient-friendly as a safe, non-
invasive and non-ionizing imaging modality [20]–[26]. The combination of US and PA imaging 
systems highlights the synergetic benefits of each modality by providing co-registered structural 
and functional information using both ultrasonic and optical contrast. The integrated information 
may lead to an improved diagnosis. In this thesis, each component of a US/PA multi-modal 
imaging system is innovatively engineered to overcome the limitations of the current configuration 
of US/PA imaging systems, such as limited imaging depth in PA imaging or limited spatial 
resolution defined by acoustic diffraction limit in US imaging. The developed imaging technique 
in this study for US/PA multi-modal imaging system can provide further clear (high signal-to-
noise ratio (SNR)) structural (ultrasonic contrast) and functional (ultrasonic/optical contrast) 
information in high spatial resolution beyond the acoustic diffraction limit. The author envision 
that the developed novel imaging techniques may provide a strong motivation and a key technical 
foundation to build a US/PA multi-modal imaging system which will be used in pre-clinical and 
clinical research, and eventual translation in the future.  
1.2 PHOTOACOUSTIC MOLECULAR IMAGING 
Combining conventional ultrasound imaging system and nano-second laser technologies, 
PA imaging is an innovative imaging modality due to its uniqueness in providing optical contrast 
at a reasonable imaging depth, while traditional optical imaging techniques are limited with either 
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imaging depth of up to only a few millimeters or poor spatial resolution [31]. Note that endogenous 
optical contrast is concerned with functional information regarding angiogenesis, hypoxia and 
invasion that are important features in cancer characterization [27]–[30]. PA imaging is an 
emerging, non-invasive and non-ionizing medical imaging technology that combines light 
excitation and US detection. In PA imaging, an acoustic wave is generated from thermo-elastic 
expansion of tissue that is a mechanical relaxation process of the stress caused by tiny, transient 
temperature increase from tissue absorption of a nanoseconds short-pulse laser excitation. If the 
laser light is delivered properly with uniform illumination to a target area, a PA image could be 
generated with every laser shot. Therefore, the imaging frame rate of PA imaging can be 
determined by the laser pulse repetition frequency and considered as a real-time operation. In 
addition, PA imaging can provide strong endogenous and exogenous optical absorption contrasts 
at a reasonable imaging depth up to 3-4 centimeters in soft tissues [32]. Most notably, multi-
spectral PA imaging can provide quantitative functional information such as variations in 
hemoglobin oxygen saturation (SO2) in addition to morphological information of an endogenous 
optical contrast of tissue[21], [22], [24]. Thus, these features of PA imaging enable visualization 
of hypoxia and necrosis in tumors, thus providing valuable information for tumor staging and 
treatment planning [33]. 
Light delivery schemes are the most restrictive of PA imaging techniques. The limited  
imaging depth of optical imaging technology such as optical coherence tomography is mainly 
attributed to high scattering of light in the tissue, resulting in decreased coherence along the depth. 
Tissue-induced light is dispersed under the skin and leads to loss of directivity and decreased echo 
to detect photons on the outside of the skin for imaging. However, PA imaging is technology based 
on transforming light energy to other types of energy, such as ultrasound, heat, or photochemical 
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reactions. Accordingly, imaging capability of PA technology depends on how deep the photons 
penetrate the tissue, regardless of their coherence. Note that PA imaging preferably uses near-
infrared (NIR) light for its transparency in soft tissue to maximize light penetration depth. PA 
imaging system can be configured differently for different applications with a wide range of 
imaging depth and spatial resolution, which are often determined by light delivery scheme as well 
as ultrasound sensor as receiver.  Figure 3 shows such scalability of PA imaging technologies with 
different configurations [34]. To achieve deep imaging depth (to at least several centimeters with 
spatial resolution of organ level, indicated by PACT), diffused light and a clinical US array 
transducer are configured to PA imaging. In this setup, imaging depth can be extended up to 3-4 
centimeters, but spatial resolution is limited to the acoustic diffraction limit (~3-500 µm, 
depending on transducer frequency response) [32], [34]. 
  
 
Figure 3. Scalability and tradeoff between imaging depth and spatial resolution in different configuration 
of PA imaging systems [34]. 
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Under configuration of PA imaging system with a linear array transducer, light energy would be 
increased to maximize light penetration depth. However, the laser exposure dose for human is 
strictly regulated by the American National Standard Institute (ANSI) through Standard Z136.1,  
“Safe Use of Lasers” due to safety issues [35]. Therefore, developing a method to effectively 
deliver light to a target through tissues within ANSI safety guidelines and more efficient PA 
contrast agent are highly called for. It is known that a large portion of incident laser energy is lost 
due to reflection on the skin surface. Such light loss directly leads to a reduction of PA signal, thus 
limiting imaging depth. To overcome this shortcoming, development of a new light delivery 
scheme that restore such energy loss at the skin surface to enhance effective laser fluence at 
imaging target depth is required.  In addition, due to restriction of laser energy for human use, a 
PA mechanism with high energy conversion efficiency from light to ultrasound will provide strong 
PA signal. Traditional PA contrast that use thermo-elastic expansion of the agent in response to a 
short-pulse laser is less effective mechanism compared to other PA contrast generation 
mechanisms such as photochemical, optical breakdown, and vaporization processes [36]–[39].  In 
recent years, optically-triggered phase transition or vaporization droplets have been introduced as 
a promising PA contrast agent [40], [41]. Short-pulse laser activated PFC-based droplets, 
especially when in a medium with a temperature below their boiling point, undergo phase changes 
of vaporization in response to pulsed-laser irradiation and generate a strong PA signal. 
Furthermore, the activated gaseous phase can be utilized as an US contrast agent. However, the 
underlying mechanism of the optically-triggered vaporization process is currently not fully 
understood due to the complexity and involvement of multiple parameters. To guide optimal 
design methodology, understanding the dynamics of laser-induced vaporization is necessary.  
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In addition to innovative PA mechanism to improve PA response, development of novel 
probes for PA imaging has been extensively studied [39], [40], [42]. There are some important 
features as an ideal efficient PA exogenous contrast agent; (1) a high absorption with low quantum 
yield at NIR region to increase penetration depth and signal-to-noise ratio (SNR), because most 
endogenous contrast such as blood [21], [43] and primary or metastatic melanoma [44] has strong 
absorption at the visible or infrared (IR) region [45], (2) high photostability which is necessary for 
a consistent long-term monitoring of biological activity progress under physiological environment 
in vivo [46], [47] and (3) high intracellular uptake or binding affinity, which determines functional 
or molecular selectivity. Most traditional organic PA contrast agents suffer from photobleaching 
or low cellular uptake [48], [49]. In addition, low toxicity is an absolute prerequisite condition for 
practical usefulness just like for any other in vivo molecular imaging modality. For example, 
quantum dots (QD) has been studied as highly resisting to photobleaching with great PA contrast 
agent [50], but its toxicity prevents QD from being widely spread for in vivo imaging study. 
Therefore, development of photo-stable, but non-toxic PA contrast agents is demanded for future 
translation.  
1.3 SUPER-RESOLUTION ULTRASOUND IMAGING 
Super-resolution ultrasound imaging technique, an innovative approach to break the 
acoustic diffraction limit for unprecedented high-spatial resolution, has promising potential for in 
vivo imaging of microvasculature such as brain vasculature or vasa vasorum that would have not 
been explored by using conventional ultrasound imaging technologies, which are inherently 
limited by the acoustic diffraction limit of clinical ultrasound scanner [51], [52]. In addition, this 
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technique can be easily applied for a broader impact for many other clinically important 
applications which are associated with abnormal microvasculature development or vascular 
degeneration/regeneration such as tumor angiogenesis indicating the likelihood of invasion and 
metastasis in cancer and kidney microvascular rarefaction from acute kidney injury [53]. Super-
resolution ultrasound imaging was inspired by the photoactivated localization microscopy 
(PALM) that awarded the 2014 Nobel Prize in Chemistry [54], [55]. The procedure of the PALM 
is briefly described here. The key component of the PALM is specially designed photo-activatable 
dye that can be stochastically activated in response to the light input. Their activation for emission 
switching depends on an excitation laser applied at low power, so that the small population of the 
dyes are photoactivated from native emissive state. Some numbers of the activated individual dye 
without having any neighbor activated dyes in a distance within the optical diffraction limit can be 
distinguishable in an imaging plane. An individual activated dye is represented by the point spread 
function (PSF) of the imaging system. Note that the PSF describes the response of a wave-based 
imaging system to a point source and its size is limited by the diffraction limit. The point source, 
the photo-activatable dye, is assumed to be located at the apex of the PSF, thus the activated dye 
location can be exactly identified. Stochastically activated-dye location maps acquired over 
multiple times, would be integrated to form the super resolution image. In US imaging, circulating 
microbubbles and a spatiotemporal filtering were utilized to achieve stochastic responses instead 
of using the photo-activatable dyes [56]. 
While recently proposed super-resolution ultrasound imaging technology is promising for 
unprecedented high-spatial resolution beyond the acoustic diffraction limit, requiring a huge 
number of frames for a super-resolved image reconstruction limits its wide spreading. The most 
significant reason is attributed to the microbubbles localization technique using 2-dimensional 
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Gaussian function (point spread function of the imaging system) that discards data points when 
detected microbubbles are clumped together [57]. Therefore, an alternative approach for effective 
center localization technique is critically needed for practical usefulness of this technology. As an 
initial effort to further develop this technique for practical application with decreased data 
acquisition time, J. Yu et al suggested deconvolution technique for localization of microbubbles 
that drastically reduced the required number of frames, while maintaining high spatial resolution 
and suggested post-processing algorithm based on the temporal correlation of independently 
fluctuating echo from microbubbles to improve temporal resolution [58]–[60]. In addition to these 
initial effort, super-resolution ultrasound imaging technology would be further tailored for future 
clinical translation in this thesis. 
1.4 LAYOUT OF THE THESIS 
In this thesis, each technical component of US and PA imaging system will be innovatively 
engineered to provide significantly improved structural and functional information in high spatial 
resolution and at deep depth.  
For further advanced PA imaging, Chapter 2 introduces a new light delivery scheme for 
enhanced PA imaging depth via compensation of light loss at the skin surface. The enhanced light 
delivery scheme can improve the signal-noise ratio of PA imaging system, leading to an increased 
imaging depth and improved image quality, which supports further translatability.  Chapter 3 
covers development of the optically-triggered phase-transition droplets and acoustical and optical 
observations of its vaporization and recondensation dynamics depending on ambient temperature 
and droplet size. These observation-based investigation leads to further understand the underlying 
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mechanism of the optical droplet vaporization and will eventually guide the design of repeatable 
phase-transition droplets as a high efficient PA imaging contrast agent. Chapter 4 presents novel 
near-infrared dyes with substantially high photostability for biomedical molecular photoacoustic 
imaging. Two strategically designed Quaterrylene-structure dyes were synthesized and evaluated 
for its photostability, cell uptake efficiency, cell viability and capability of photoacoustic imaging 
using MDA-MB-231 cells. Chapter 5 explores novel signal processing and imaging sequence of 
US imaging to overcome the physical barrier of the spatial resolution of US imaging with high 
temporal resolution using novel deconvolution and spatio-temporal-interframe-correlation based 
acquisition. In vivo feasibility of the developed technologies is evaluated in rabbit atherosclerotic 
plaque model. Finally, Chapter 6 discusses the implications of these work on translational efforts 
motivated by these studies. 
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2.0  A LIGHT ILLUMINATION ENHANCEMENT DEVICE FOR 
PHOTOACOUSTIC IMAGING: IN VIVO ANIMAL STUDY 
The work presented in this chapter was reprinted, with permission, from J.Yu, J. 
S. Schuman, J-K. Lee, S-G. Lee J. H. Chang, and K. Kim, “A light illumination 
enhancement device for photoacoustic imaging: in vivo animal study,” IEEE 
Transaction on Ultrasonics, Ferroelectronics, and Frequency Control, vol. 64, no. 
8, pp. 1205–1211, Aug. 2017. © 2017 IEEE. This work featured on the front cover. 
 
Photoacoustic (PA) imaging detects acoustic signals generated by thermal expansion of 
light excited tissue or contrast agents. PA signal amplitude and image quality directly depend on 
the light fluence at the target depth. With conventional PA imaging systems, approximately 30% 
energy of incident light at the near-infrared region would be lost due to reflection on the skin 
surface. Such light loss directly leads to a reduction of PA signal and image quality. A new light 
delivery scheme that collects and re-distributes reflected light energy was recently suggested, 
which is called the light catcher. In our previous study, proof-of-concept using a finite-element 
simulation model was shown and a laboratory built prototype of the light catcher was applied on 
tissue mimicking phantoms. In this study, we present an elaborate prototype of high-frequency PA 
probe with the light catcher fabricated using 3D printing technology, which is conformal to a 
subcutaneous tumor in mice. The in vivo usefulness of the developed prototype was evaluated in 
a mouse tumor model. Equipped with the light catcher, PA signal amplitude from the clinical 
photosensitizer injected into the mouse tumor was enhanced by 33.7%, which is approximately 
equivalent to the percent light loss due to reflection on the skin. 
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2.1 INTRODUCTION 
Photoacoustic (PA) technology is a promising state-of-the-art medical imaging modality 
to quantitatively provide a real-time optical contrast at depth by using energy conversion from 
absorbed light energy to acoustic wave in tissue tissue [23]. In PA imaging, initial local PA 
pressure and PA image quality are directly affected by laser fluence. In the past years, various 
efforts have been made to further understand light propagation in the tissue and use them to 
improve light penetration in tissues with limited success. Kwon et al. suggested simulation model 
analyzing light propagation in the multiple layers of skin using mathematical models [61]. They 
concluded that adjusting incident beam power and diameter, physically compressing tissue, or 
using chemical agents can affect the light penetration depth. With such understanding, Yeo et al. 
developed a compression-controlled low-level laser probe to increase photon density in soft tissue 
with the negative mechanical compression control technique [62]. They successfully demonstrated 
a concentrated beam profile with enhanced laser photon density using their probe. Zhaohui et al. 
suggested a new light illumination scheme for deep tissue PA imaging and the proof-of-concept 
was shown through a finite-element simulation [63]. The proposed scheme was based on a fact 
that light energy is considerably lost by reflection at the skin surface depending on the incident 
angle. For example, experimental observation revealed that approximately 22-29% of light at 800 
nm reflects off human skin with an incident angle of 20° [64]. Moreover, it is known the reflectance 
of 800 nm light increased by 13% (from 19 to 32%) as skin thickness increases from 0.43 to 1.60 
mm [65]. Therefore, only approximately 70% of the near infrared (NIR) light is expected to 
penetrate into the tissues to excite targets in depth. For the safety of human use, the maximum 
amount of allowed NIR light fluence exposure in PA imaging should comply with the laser 
exposure safety guideline of American National Safety Institute (ANSI, Z136.1 – Safe Use of 
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Lasers). To overcome this shortcoming, a device called the light catcher was developed to restore 
energy loss at skin surface by collecting and redistributing reflected laser energy onto soft tissue 
and therefore enhancing the effective laser fluence. The proposed light catcher is a relatively 
simple concave shape light reflector integrated with an optical fiber bundle that is attached to an 
ultrasound probe. To collect and redistribute the light bounced off the skin surface, the inner 
surface of the cavity was coated with silver that highly reflects (> 90%) light at the NIR region 
[66]. In addition to an increase in light fluence at the skin surface, a more uniform distribution of 
the laser energy at depth caused by random light reflection between the silver coating surface and 
skin surface was shown in the experiments using a tissue-mimicking phantom [63]. A conceptually 
similar technology was applied on a photoacoustic tomography system for brain imaging by Nie 
et al [67]. This device called the photon recycler that was designed to recycle scattered photon 
from the skin surface showed enhanced light transmittance ex vivo through a human skull. In our 
previous report by Yu et al., we manufactured an elaborate prototype light catcher for freehand 
scanning using 3D printing technology and integrated into a custom made high-frequency 
ultrasound imaging probe [68]. The developed system was tested in vitro. In this study, we further 
investigated and quantitatively evaluated in vivo the effectiveness of the developed hand-held light 
catcher that was designed for small animal tumor study. 
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2.2 MATERIALS AND METHODS 
2.2.1 Photoacoustic imaging 
Initial local photoacoustic (PA) pressure rise p0 by thermal expansion after a short pulse 
laser excitation can be expressed by Eq.1 with assumptions that the absorbed optical energy is 
completely converted into heat energy and non-thermal relaxation such as fluorescence is enough 
small to be negligible [69]. 
𝑝𝑝0 = 𝛤𝛤𝜇𝜇𝑎𝑎𝐹𝐹                                                                (1) 
where 𝛤𝛤 is the Grüneisen parameter associated with thermodynamic property of tissue, μa is an 
absorption coefficient, and F denotes laser energy fluence [67]. The Grüneisen parameter is given 
by Γ = α / (κρCp), where α is the isobaric volume thermal expansion coefficient, κ is the isothermal 
compressibility, ρ is density of the medium, and Cp is the specific heat capacity. Therefore, the 
initial local PA pressure is directly proportional to laser fluence. Given input power of the laser, 
the light catcher is designed to maximize the laser delivery at depth for higher PA signal amplitude 
and therefore increased imaging depth. 
 
2.2.2 The light catcher: a prototype manufacturing 
A concave shape light catcher (Hollow hemisphere, Height: 12.7 mm, Diameter: 25.4 mm) 
designed for a typical mouse subcutaneous tumor model was drawn by 3D computer-aided design 
(CAD) software (Solidworks 2012, Dassault Systèmes SOLIDWORKS Corp, MA, USA). Figure 
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4 illustrates 3D CAD drawing of the light catcher and the prototype of the light catcher in different 
views.  
 
Figure 4. The developed high-frequency ultrasound transducer integrated with the light catcher for PA 
imaging. (a, b) 3D drawing of the light catcher prototype. All parts were fabricated using 3D printing 
technology. (a,d) The handheld style housing was made for freehand scanning. (b,c,e) The detailed 
configurations of the ultrasound transducer and bifurcated optical fiber bundle integrated with the light 
reflecting mirrors. The angle between the transducer and the optical fiber is 30°. The concave shape light 
catcher is 12.7 mm in height and 25.4 mm in diameter. The light catcher inner surface was coated with 
silver. (f) For experimental evaluation of the device under the same geometrical setups of the optical fiber 
and the ultrasound transducer, two types of insertion with and without the light reflecting mirror were built. 
UT: Ultrasound transducer; w/ LC: with the light catcher; w/o LC: without the light catcher 
 
All parts shown in Figures 4(c)-(e) were produced by a stereolithography 3D-layering printer 
(Viper SLA system, 3D systems, Rock Hill, SC, USA) using water-resistant resin materials of high 
dimensional stability (Somos WaterShed XC11122, DSM, Heerlen, Netherlands). Silver was 
chosen as a coating material that is highly reflective (> 95%) in the NIR range. The silver coating 
process was performed at room temperature due to relative low glass transition temperature (Tg, 
39-46°C) of the 3D-printing material. A pair of custom-made optical fiber bundles (NA: 0.55, Core 
diameter: 50 μm, Fiber bundle width: 1.3 cm, Fiberoptic Systems Inc, Simi Valley, CA, USA) was 
integrated through two slits made in the concave reflecting mirror as shown in Figure 4(c). The 
incident angle of each laser beam was designed to be 30° from the major axis of an ultrasound 
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transducer to maximize the overlap area of two beams at the equator of the cavity. Approximate 
beam size at the equator of the light catcher (opening) is 2 cm x 1.3 cm. Multiple random 
reflections between the light catcher inner surface and the skin surface are expected that might 
result in more uniform light distribution in tissue. To keep the geometrical setups of the optical 
fiber and the ultrasound transducer unchanged between experiments, a duplicate light catcher 
insertion without a concave reflecting mirror was fabricated as shown in Figure 4(f). 
2.2.3 Experiment setup of PA imaging 
Figure 5 illustrates that the PA imaging system consists of a commercial clinical ultrasound 
scanner equipped with research package (SonixTouch, Analogic corporations, Peabody, MA, 
USA) to collect raw PA radio frequency (RF) data and an optical parametric oscillator tunable 
laser pumped by Nd:YAG Q-switched laser (Vibrant HE532I, OPOTek, Carlsbad, CA, USA) as a 
PA excitation source, with time synchronization between them. The laser wavelength can be tuned 
within 680-950 nm range. The short laser pulse of 5 ns-long was delivered through the custom 
made bifurcated optical fiber bundles (Fiberoptic Systems Inc., Simi Valley, CA, USA) attached 
to both sides of an ultrasound transducer. The laser pulse fluence (<10 mJ/cm2 at 689 nm and <15 
mJ/cm2 at 800 nm) was kept within ANSI safety limit. A custom built 128-element high-frequency 
linear array transducer centered at 15 MHz with the full-width-half-maximum bandwidth of 65% 
for small animal imaging with a footprint of 15 mm long and 10 mm wide (iBule photonics, 
Incheon, South Korea) was connected to the ultrasound imaging system. The ultrasound gel was 
centrifuged to remove air bubbles before it was carefully applied on the inner surfaces of the light 
catcher and the subcutaneous tumor. The light catcher then was deliberately placed from one side 
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of the tumor to avoid trapping bubbles. Any excessive gel was removed upon completion of 
positioning.  
 
Figure 5 (a) Experimental setups for ex vivo tissue and in vivo animal study. A commercial research 
ultrasound scanner was synchronized with a tunable laser system. A short laser pulse of 5 ns long was 
delivered through a bifurcated optical fiber attached to both sides of the US transducer. The concave 
reflecting mirror of the light catcher was placed on the target covered with ultrasound gel. (b) Laser fluence 
was measured at different depths (5, 10, and 15 mm) in chicken breast tissues (thickness of each tissue slab: 
5 mm) at 689 and 800 nm (c) PA signal was measured from a polyethylene tube (Inner diameter: 580 μm, 
Outer diameter: 965 μm) filled with a contrast agent that was placed between chicken breast tissues of 
varying thickness. (d) For in vivo animal study, a contrast agent was locally injected into a subcutaneous 
tumor (Diameter: 1 cm) on the back of a mouse. 
 
For PA image reconstruction, the acquired raw PA RF data were processed off-line using delay-
and-sum one-way dynamic receive beamforming. An envelope was extracted from the summed 
RF data applied with the Hilbert transform for PA image reconstruction. Ultrasound B-mode 
imaging was performed with 15 MHz transmit beam to focus at 10 mm depth. Acquired raw pulse-
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echo RF data were processed using a conventional B-mode processing method; delay-and-sum 
dynamic receive beamforming, a band-pass filter (Bandwidth: 10.5-19.5 MHz) and, envelope 
detection using the Hilbert transform. The PA signal amplitudes were normalized to the measured 
averaged laser fluence over 50 laser pulses measured near the laser source output via using a laser 
sensor (YAG EnergyMax, J-50MB-YAG, Coherent Inc., Santa Clara, CA, USA). 
2.2.4 Photoacoustic contrast agents 
In this study, a clinical photosensitizer that has an absorption peak at 689 nm in NIR was 
employed as a PA imaging agent. The NIR region is the most preferred wavelength range for in 
vivo PA imaging due to relatively low background absorption by both water and blood. 
Visudyne®, also known as verteporfin (Liposomal verteporfin for injection, benzoporphyrin 
derivative monoacid ring A, BPD-MA; Valeant Pharmaceuticals North America LLC, 
Bridgewater, NJ, USA) is FDA approved photosensitizer that has been used in photodynamic 
therapy (PDT) for an anatomical treatment for vaso-occlusion of the arteriolarized neovessels. 
Even though the strongest absorption peak of the photosensitizer is nearby 430 nm (blue light), the 
absorption peak wavelength in the NIR, 689 nm, is mostly preferred for the PDT in the clinic as 
shown in Figure 6(a). The blue light attenuates quickly because of hemoglobin that has strong 
absorption in the same wavelength range. Instead, the sharp secondary peak at 689 nm, albeit 
relatively small absorption magnitude, can be used for in vivo PA imaging, as background 
absorption by hemoglobin, fibrotic tissue, or a skin chromophore such as melanin is relatively low 
at this wavelength. A solution of the photosensitizer was prepared with dose for human 
administration guidance written in the manufacturer’s instruction. A vial of the photosensitizer of 
15 mg was reconstituted with 7 mL of sterile water for injection resulting in the dark green colored 
 20 
mother solution of 3.0 mM while the molar weight of the photosensitizer is 718.8 g/mol. The 
prepared mother solution was kept in dark storage to protect from ambient light. According to the 
clinical administration guideline, it would be diluted by using 5% dextrose to achieve a required 
dosage of the photosensitizer, 6 mg/m2 of body surface area and the required total volume was 30 
mL. Therefore, the clinical molar concentration of the photosensitizer should be kept under 0.7 
mM. In addition, to test the light catcher efficiency at a different wavelength in NIR, indocyanine 
green (ICG) solution of 65 µM with an absorption peak at 800 nm as shown in Figure 6(b) was 
used in ex vivo experiment [70]–[72]. The ICG solution was prepared by mixing the ICG powder 
of 50.4 μg and distilled water of 1 mL. Note the molar weight of the ICG is 774.96 g/mol. 
 
Figure 6. Normalized absorption spectrums of the verteporfin solution (a) and the ICG solution at 65 μM 
(b). In addition to its major absorption peak at the visible light at nearby 430 nm (Blue light), a distinct 
secondary absorption peak of verteporfin in the NIR at 800 nm. 
2.2.5 Ex vivo experiment using chicken breast tissues 
Fat and blood removed chicken breast tissues were used for an ex vivo evaluation of the 
developed light catcher. To support the light fluence enhancement at the target depth when using 
the light catcher, laser pulse energy was measured at the same depth, maintaining all experimental 
conditions same. Laser energy was measured over 50 times by using the laser sensor covered with 
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thin clear plastic lab wrap (VWR, PA, USA), reducing variations from pulse-to-pulse laser energy 
fluctuation, at the bottom of the stacked chicken breast tissues with different thickness of 5, 10, 
and 15 mm, and compared with when the light catcher was not used as shown in Figure 5(b). Each 
chicken breast tissues were prepared with the size of about 20 mm (width) × 20 mm (length) × 5 
mm (thickness). To compare corresponding PA signal enhancement due to increased light energy, 
a polyethylene tube (PE-50, Inner diameter: 580 μm, Outer diameter: 965 μm, Becton Dickinson, 
Sparks, MD, USA) filled with PA contrast agents was placed below three stacked chicken breast 
tissues of the `total thickness of 15 mm. A separate large piece of chicken tissue of 20 mm 
thickness was placed at the bottom of the tube. Top and bottom chicken breast tissues were fixed 
by using pin nails. Centrifuged ultrasound gel was carefully applied to fill up the cavity of the light 
catcher before gently placing it onto the prepared chicken breast tissues. A thin layer of ultrasound 
gel also was applied between the layers of the tissue. To test the consistency of the performance 
in different NIR wavelengths, two different PA contrast agents were introduced at a time into the 
PE-50 tube embedded in the chicken tissue; verteporfin solution with an absorption peak at 689 
nm and ICG solution with an absorption peak at 800 nm (Figure 6). PA images on short axis of 
the tube were acquired for both contrast agents using the laser pulse tuned at each absorption peak 
with and without the light catcher at the same depth. Mean and standard deviation of PA signal 
amplitude were calculated over tube area of each PA image. For each dye, PA images when using 
and without using the light catcher were shown in same dynamic range after being normalized to 
the peak PA signal amplitude when using the light catcher. The statistical significance was 
measured between mean values of paired PA images (with using the light catcher vs without using 
the light catcher) by using t-test. 
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2.2.6 In vivo experiment using mouse tumor model 
EMT-6 breast cancer cells acquired from the American type culture collection (ATCC, Manassas, 
VA, USA) were cultured in Waymouth’s MB 752/1 with L-glutamine culture medium (Gibco, 
Life Technologies, Grand Island, NY, USA) added with 15% fetal bovine serum albumin (FBS, 
Atlanta biological, GA, USA) and 2% penicillin-streptomycin (Lonza, Basel, Switzerland). Cells 
were cultured in the cell incubation t-flask chamber at 37°C with 5% CO2 condition until reaching 
a number of cells > 8×106. Cultured cells were withdrawn from incubated t-flask to a vial of 1×106 
cells for each mouse. Each sample was washed 3 times and suspended in 0.2 mL hyclone hank’s 
balanced salt solution (HBSS, Thermo Scientific, South Logan, UT, USA). Tumors were 
developed on 6-weeks old female BALB/c-albino mouse by subcutaneously injecting cells on her 
lower back. Tumor-bearing mice were taken care of until each tumor size reached up to 10 mm in 
diameter (Figure 5(d)). The prepared verteporfin solution of 50 µL (3.0 mM) was locally 
administrated into the center of tumor of each anesthetized mouse using an injection needle of 
gauge 26. PA signal amplitudes from injected verteporfin were measured when using and without 
using the light catcher. For each animal, the paired PA images were normalized to the maximum 
PA signal intensity in the PA image when using the light catcher. All images are shown in the 
same normalized dynamic range. The total number of mice used in this study was 8 and 
significance of the measurements were determined by calculation of p-value using t-test statistical 
analysis. The in vivo animal study was conducted under an approved protocol of Institutional 
Animal Care and Use Committee (IACUC) of University of Pittsburgh. 
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2.3 RESULTS AND DISCUSSIONS 
2.3.1 Ex vivo study: Light delivery enhancement with the light catcher in chicken breast 
tissues 
Figure 7 compares laser energy at different depths in the chicken breast tissues between 
the cases when using and without using the light catcher. The white and black bars represent the 
mean value of measured laser energy with and without applying the light catcher, respectively, at 
3 different depths of 5, 10, and 15 mm, with an error bar of the standard deviation over 50 
measurements. Using the light catcher increases the laser energy by 27.9% (17.3±1.1 mJ vs 
12.3±0.8 mJ, p<0.05, when using the light catcher vs without using the light catcher for the rest of 
this paper) and 33.3% (26.4±1.5 mJ vs 17.8±1.0 mJ, p<0.05) at 5 mm, 31.0% (11.7±0.7 mJ vs 
8.1±0.5 mJ, p<0.05) and 34.9% (17.4±1.0 mJ vs 11.2±0.7 mJ, p<0.05) at 10 mm, and 30.4% 
(9.4±0.6 mJ vs 6.3±0.4 mJ, p<0.05) and 34.4% (13.0±1.0 mJ vs 8.5±0.6 mJ, p<0.05) at 15 mm for 
689 nm (a) and 800 nm (b), respectively. Note that the measured laser energy without chicken 
breast (at depth 0 mm) are considered as same for both cases when using or without using the light 
catcher at each wavelength (36.3±1.1 mJ vs 35.6±0.9 mJ, p<0.05 for 689 nm, 57.7±1.5 mJ vs 
57.3±1.3 mJ, p<0.05 for 800 nm). One of the limitations of this experiment is that laser pulse 
energy was measured instead of local laser fluence that directly affects initial local PA pressure 
because measuring local laser fluence could be erroneous without being able to know exact light 
propagation paths and beam profile. However, we believe that the increment ratio of total through-
transmission of laser energy with the device would be very close to if not exactly same as the 
increment ratio of local laser fluence, while all experimental conditions were maintained the same. 
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Figure 7. Ex vivo experiment results: Measured laser energy at 689 nm (a) and 800 nm (b) at different 
depths in chicken breast tissues. Laser energy is measured at 5, 10, and 15 mm depth of chicken breast 
tissues with (white) and without (black) the light catcher. Each bar represents the mean of laser energy over 
50 measurements with an error bar of the standard deviation. w/o LC: without the light catcher; w/ LC: with 
the light catcher. 
 
Figure 8 shows short-axis PA images from a tube filled with two different dyes embedded 
in chicken breast tissue at depth of 15 mm; verteporfin in (a) and ICG in (b). A white dotted circle 
represents the tube with inner diameter of 580 μm as a region of interest (ROI). PA signals were 
only detected on the top and bottom of the tube due to the linear array transducer’s geometrical 
limited view [72], [73]. When using the light catcher, PA signal amplitudes over the tube area for 
both agents were significantly enhanced as shown in Figure 8(c); verteporfin at 689 nm: 37.6% 
enhancement, PA amplitudes of 39.9±11.7 vs 24.9±4.4, and ICG at 800 nm: 32.5% enhancement, 
PA amplitudes of 70.2±26.7 vs 47.4±16.1. A significant difference with p<0.05 using t-test was 
shown for both cases. PA signal enhancement in two different wavelengths of 689 nm and 800 nm 
are in good agreement with laser fluence increase shown above and our previous in silico and in 
vitro results [63], [68]. This experiment result implies that PA signal would be amplified by 
increased laser fluence at depth when using the light catcher. 
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Figure 8. Ex vivo experiment results: Short-axis PA images from a tube filled with (a) verteporfin taken at 
689 nm and (b) ICG taken at 800 nm that was embedded in chicken breast tissue at depth of 15 mm. The 
left panels are for the case without using the light catcher and the right panels are for the case when using 
the light catcher. White dotted circles represent a polyethylene tube. (c) PA signal was enhanced by 37.6% 
for verteporfin at 689 nm and by 32.5% for ICG at 800 nm. 
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2.3.2 In vivo study: PA signal enhancement with the light catcher in mouse tumor model 
A representative PA image overlaid on ultrasound B-mode image is shown in Figure 9(a). 
Ultrasound B-mode image was log-compressed with 40 dB dynamic range. The yellow dashed 
contour draws the tumor of the mouse, and the top layer of the tumor is hair-removed skin. The 
white dashed box (Height: 1.2 mm, Width: 2.0 mm) in the image indicates the injection site within 
the tumor volume. The bright color at the center of the region of interest (ROI) indicates PA signal 
from the injected photosensitizer. The PA signals with much lower amplitudes found in the 
periphery of ROI are believed to be from the vascular network. In Figure 9(b), the reconstructed 
PA images in ROI of animal tumor models with and without the light catcher are compared next 
to each other. Overall, PA images acquired when using the light catcher (bottom panels in each 
row) clearly exhibit with higher signal levels than without using light catcher (top panels in each 
row). 
Table 1 summarizes PA signal amplitudes averaged over ROI from each mouse and PA 
signal enhancement ratio of with and without the light catcher. With the light catcher, the 
percentage of PA signal enhancement ranges from 26.1% (mouse no. 4) to 37.0% (mouse no. 8) 
with an average of 33.7%. The statistical power analysis is shown in Figure 9(c). Circles represent 
the averaged PA signal amplitudes within ROI of each mouse with the light catcher, and triangles 
are averaged PA signal amplitudes without the light catcher. Central line in the boxplot represents 
the median, and both edges of the box indicate 25th and 75th percentiles. Two whiskers above and 
bottom of the boxplot display the range of measurements for the maximum and the minimum 
value, respectively. A p-value lower than 0.05 determines that PA signal level is significantly 
enhanced by an average of 33.7% when using the light catcher. 
 27 
 
Figure 9. In vivo experiment results: Normalized PA images with and without the light catcher. (a) PA 
image overlaid on ultrasound B-mode image with 40 dB log-compression. The yellow dashed contour 
represents the tumor location of the mouse and the top layer of the tumor is skin with hair removed. The 
white dashed box (Height: 1.2 mm, Width: 2.0 mm) indicates the region of interest (ROI) where the 
photosensitizer is administered. (b) PA images of ROI when using (Lower row) and without using the light 
catcher (Upper row) for each mouse (n = 8) within a depth of 14.6-15.8 mm. All PA images are normalized 
by measured laser fluence and shown in same dynamic range. (c) Statistical analysis of in vivo study results 
(Table 1). Solid circles and triangles represent averaged PA signal amplitudes in ROI with and without the 
light catcher, respectively. The central line of the boxplot is median, the edges of the box are 25th and 75th 
percentiles, and two whiskers above and below of the box are the maximum and the minimum of 
measurements. 
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Table 1. In vivo experiment results: The normalized and averaged PA signal amplitude (a.u.) in 
the ROI and enhancement ratio when using the light catcher. 
Mouse No. 1 2 3 4 5 6 7 8 
PA amplitude w/o LC* 0.46 0.45 0.42 0.49 0.44 0.44 0.44 0.45 
PA amplitude w/ LC* 0.68 0.67 0.66 0.66 0.70 0.66 0.65 0.71 
Enhancement (%) 32.8 32.9 34.9 26.1 36.9 32.9 31.6 37.0 
Averaged enhancement (%) 33.7 
*PA signal amplitude of each mouse was mean value in ROI of the injected photosensitizer (n = 8). PA 
signal amplitudes were normalized by the laser fluence. All values are in arbitrary unit (a.u.). w/o LC: 
without the light catcher; w/ LC: with the light catcher. 
 
 
In summary, enhancement of the laser fluence in tissues using the developed light catcher 
is evidenced by the increased PA signal amplitudes measured ex vivo in the chicken breast tissues. 
In an in vivo study using the mouse tumor model, significantly improved PA amplitudes are 
observed when using the light catcher. This suggests the potential of an increased PA imaging 
depth when using the light catcher. In addition, the light catcher may protect the operator and the 
subject from unwanted exposure of laser excitation that may allow free-hand PA imaging without 
needing eye protection goggles. For further translation of this technology and device, a few 
technical challenges have to be overcome. The current prototype of the reflecting mirror cone is 
fabricated using rigid, opaque material that makes difficult to use it on non-flat skin surfaces and 
prevents the operator from seeing the scanning area. Materials that are mechanically compliant 
and optically transparent to visible light, yet still reflective to the NIR, will be ideal for the 
reflecting mirror cone. In addition, the cone will have to be reasonably flat as well for easier free-
hand scanning, without potentially trapping air bubbles inside. As long as the cone fully covers 
the skin surface, a similar efficiency can be expected for different geometry. Moreover, the light 
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catcher can be applicable to other optic-based technology such as PDT that is expected to increase 
light delivery efficiency thus for potentially improved treatment. 
2.4 CONCLUSION 
Significant PA signal enhancement by about 33.7 % is shown when using the developed 
light catcher in an in vivo mouse tumor model injected with a clinical photosensitizer, verteporfin 
that has an absorption peak at 689 nm in NIR. Such enhancement of PA signal amplitude is mainly 
attributed to improved effective laser fluence at the target depth when using the light catcher that 
collects and re-distributes the reflected light. This is further supported by both increased laser 
fluence and PA signal intensity in ex vivo chicken breast tissues experiments when using the light 
catcher. All these ex vivo and in vivo experiment results are in good agreement with our earlier 
simulation model [63], [68]. 
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3.0  VAPORIZATION AND RECONDENSATION DYNAMUCS OF INDOCYANINE 
GREEN-LOADED PERFLUOROPENTANE DROPLETS IRRADIATED BY A SHORT 
PULSE LASER 
The work presented in this chapter was reprinted from J.Yu, X. Chen, F. S. Villanueva and K. Kim, 
“Vaporization and recondensation dynamics of indocyanine green-loaded perfluoropentane 
droplets irradiated by a short pulse laser”, Appl. Phys. Lett. 109, 243701 (2016); doi: 
10.1063/1.4972184, with the permission of AIP Publishing. © 2016 AIP.  
 
Phase-transition droplets have been proposed as promising contrast agents for ultrasound 
and photoacoustic imaging. Short pulse laser activated perfluorocarbon-based droplets, especially 
when in a medium with a temperature below their boiling point, undergo phase changes of 
vaporization and recondensation in response to pulsed laser irradiation. Here, we report and discuss 
the vaporization and recondensation dynamics of perfluoropentane droplets containing 
indocyanine green in response to a short pulsed laser with optical and acoustic measurements. To 
investigate the effect of temperature on the vaporization process, an imaging chamber was 
mounted on a temperature-controlled water reservoir and then the vaporization event was recorded 
at 5 million frames per second via a high-speed camera. The high-speed movies show that most of 
the droplets within the laser beam area expanded rapidly as soon as they were exposed to the laser 
pulse and immediately recondensed within 1-2 µs. The vaporization/recondensation process was 
consistently reproduced in six consecutive laser pulses to the same area. As the temperature of the 
media was increased above the boiling point of the perfluoropentane, the droplets were less likely 
to recondense and remained in a gas phase after the first vaporization. These observations will help 
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to clarify the underlying processes and eventually guide the design of repeatable phase-transition 
droplets as a photoacoustic imaging contrast agent. 
3.1 INTRODUCTION 
Perfluorocarbon (PFC) based optically-triggered phase-transition droplets have been 
recently introduced as a promising contrast agent for photoacoustic (PA) imaging [40], [41], [74], 
[75]. These PFC-droplets contain a light absorber that increases PFC core temperature with a light 
input, causing the phase transition from liquid to gas. The resulting rapid expansion of the droplet 
volume provides significant PA contrast enhancement compared to PA contrast via thermal 
expansion [76]. Furthermore, once vaporized, echogenicity also dramatically increases to a degree 
similar to that conferred by microbubbles designed as ultrasound (US) contrast agents. There have 
been various efforts to utilize optically-triggered droplets for more efficient medical PA imaging 
techniques. Strohm et al. demonstrated optically-triggered micron-sized PFC droplets, loaded with 
silica-coated lead sulfide nanoparticles, which work as a contrast agent for PA and US imaging 
[74]. They described that the PA signal amplitude from the vaporization is linearly proportional to 
the light absorber payload. Wilson et al. demonstrated contrast enhanced PA imaging using nano-
sized PFC droplets containing gold nanorods [40]. PA signal via vaporization was several times 
higher than PA signal via thermal expansion in vivo. Subsequently, Hannah et al. developed an 
indocyanine green (ICG) loaded nano-sized PFC droplets for contrast-enhanced US and PA 
imaging in response to a laser excitation [41]. In their study, the PA signal increased as the PFC 
became superheated and volatile at a higher ambient temperature and therefore vaporized more 
easily with the same input laser fluence. Later, Asami et al. found repeatability of optically-
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triggered droplet vaporization (ODV) that depended on the size of droplets [77]. Up to three times 
more enhanced PA signals - compared to PA signals from thermal expansion - were continually 
observed by repeated vaporization and recondensation processes of droplets 0.2-1.0 μm in 
diameter. However, the underlying mechanism of the ODV has not been fully unveiled due to the 
complexity and involvement of various parameters in the above studies. Lajoinie et al. observed 
the dynamics of the vaporization process of micron-sized PFC droplets under controlled 
environments using a high-speed camera. They suggested a model incorporating thermal diffusion 
of the heated hexadecane core with an ambient medium through the droplet shell [78]. In the 
present study, the phase transition dynamics of droplets undergoing the repeated vaporization and 
recondensation process in response to each short pulse laser and resulting PA signals were further 
investigated by concurrently recording acoustic signals and vaporized droplet shell motion 
dynamics. The relationship between PA signal amplitude and droplet size was determined and 
compared with those of the analytical model. The stability of the droplet, which showed 
dependency on the size and the ambient temperature, is discussed; these observations may help 
guide droplet design and lead to further advanced investigation. 
3.2 MATERIALS AND METHODS 
3.2.1 Synthesis of PFC droplet 
Droplets were synthesized using an adapted method previously reported by other groups 
[41], [79]. Droplets contained perfluoropentane (PFP, C5F12, Boiling point of 29°C, Fluoromed) 
as a phase-transition medium, bovine serum albumin (BSA, Sigma-Aldrich) shell, and ICG 
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(Sigma-Aldrich) for localized volume heating with a laser input. Initially, blank droplets were 
emulsified by sonication (75D, VWR) using a mixture of PFP 0.3 mL and BSA solution (2 mg/mL) 
2.7 mL in an iced water bath. Blank droplets were aspirated from the upper layer while residual 
PFP solution sank to the bottom. ICG was encapsulated by sonicating a mixture of 1 mM ICG and 
6 mM tetrabutylammonium iodide (Sigma-Aldrich) solution in chloroform. The prepared ICG 
solution was supplemented dropwise with blank PFC droplets using a stirrer at 1,200 rpm 
(IsoTemp, Fischer Scientific). The droplets in the suspension were carefully extracted and then 
washed three times by discarding the light-green colored supernatant after centrifuging. The 
absorption peak of the droplet is around 800 nm. The design of a droplet is illustrated in Figure 
10(a). Confocal fluorescence microscopy images (IX-81, Olympus) taken from a droplet pre- and 
post- vaporization are shown in Figure 10(b). ICG in the core of the droplet before vaporization 
was pushed into the outer-shell after vaporization. 
 
Figure 10. Schematic of the ICG-loaded PFP droplets (a); Confocal fluorescent microscopy image of a 
droplet (b) before vaporization (Left panel) and after vaporization (Right panel). 
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3.2.2 Experiment setup 
To obtain a sufficient temporal resolution for optical observation of the dynamics of an 
ODV, high-speed microscopy with a water-immersion objective lens (LUMPLFLN ×60, 
Olympus) was employed (Figure 11) [80]. An Opticell cartridge (ThermoScientific), injected with 
the sample suspended in equilibrated, gas-saturated de-ionized water to be investigated, was placed 
on the top of a temperature-controlled reservoir filled with de-ionized water. No investigation on 
potential effects by medium viscosity was performed in this study. The reservoir contained a 
focused single-element ultrasound transducer (V306-SU, 2.25 MHz, 60% bandwidth, Olympus) 
for PA signal detection. The transducer focus was co-aligned with the optical focus of the 
microscope, at an angle of 45° from the Opticell membrane. The detected PA signal was amplified 
by an ultrasonic receiver (PR-5900, Olympus) and digitized (WaveSurfer 452, Lecroy). The 
receiver circuitry was calibrated by using theories developed previously [81]–[83].  A strobe light 
(MVS-700, PerkinElmer), triggered from the camera timing board, was used as the light source 
for bright-field imaging. A laser pulse of 5-ns-long tuned at 800 nm by an optical parametric 
oscillator (Vibrant HE532I, OPOTEK) was delivered through a custom-made optical fiber (OZ 
optics) aligned with the microscopy. The excitation laser spot size of homogeneous Gaussian 
distribution was set to be around 40 μm in diameter to assure only individual droplet can be 
optically-activated.9 The laser fluence exposed to the sample was estimated to be 1.2 J/cm2. A 
near-infrared (NIR)-reflected dichroic mirror (ZT660DCSPXR, Chroma) was installed in a right-
facing cube (IX2-MFB-SP-R, Olympus) to align the two optical paths: white light for imaging (red 
arrow in Figure 11) and NIR light for ODV (green arrow in Figure 11). An emission filter (FF01-
650, Semrock) was used to reject any interference with excitation laser on recorded videos. These 
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three independent systems - an ultrasound measurement system, a high-speed camera, and a laser 
system - were synchronously interfaced by a custom-made timing controller. To calculate the 
acoustic pressure radiated from a droplet that undergoes rapid expansion and compression, radius-
time curve was measured on the recorded high-speed video. Measured radius were interpolated, 
and then plugged into the analytical model for acoustic pressure estimation from a spherical bubble 
described by  
𝑃𝑃(𝑟𝑟, 𝑡𝑡) = 𝜌𝜌𝑙𝑙 𝑅𝑅(𝑡𝑡)𝑟𝑟 �2?̇?𝑅(𝑡𝑡)2 + 𝑅𝑅(𝑡𝑡)?̈?𝑅(𝑡𝑡)�                                       (2) 
 
where ρl is the liquid density, R(t) is the droplet radius, ?̇?𝑅(𝑡𝑡) is the shell velocity, ?̈?𝑅(𝑡𝑡) is the shell 
acceleration, and r indicates the radial location in a spherical coordinate system [78], [84], [85]. A 
bandpass filter (0.5-3.2 MHz) was applied to the calculated pressure. All analyses were performed 
in MATLAB (Mathworks). 
 
Figure 11. Experiment schematic. A high-speed optical microscopy apparatus equipped with a water 
immersion objective lens (60×) was combined with NIR laser for PA excitation. Short pulse laser of 5 ns 
duration tuned at 800 nm was illuminated onto the target though the objective lens. Acoustic signal from 
vaporization was captured by a single element focused ultrasound transducer. Green and red arrows 
represent the light paths of the excitation laser for vaporization and white light for brigthfield imaging, 
respectively. Acoustic and optical systems were aligned on the focal plane of the sample and synchronized 
through a custom-made FPGA-based timing controller. T/R: Transmitter/Receiver, OSC: oscilloscope. 
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3.3 RESULTS AND DISCUSSIONS 
A directly recorded PA signal from individual droplet was compared with the estimated 
acoustic pressure using an analytic model for two different size droplets. Figure 12 depicts selected 
frames cropped from the high-speed movies at every 0.2 μs during the vaporization (transient 
expanding) and recondensation (transient shrinking) processes of a large (Diameter: 4.8 μm) and 
a small (Diameter: 2.0 μm) droplet. The concurrently recorded acoustic emissions by the 
ultrasound transducer was compared with the pressure estimated using the analytic model in Eq. 2 
at room temperature (20°C) as shown in Figures 12(c, f). Note that a single laser pulse was used 
to excite the sample at time 0 μs. For the larger droplet, the radius increased from 2.4 to 8.3 μm - 
approximately 3.5 times. The first 0.8 μs during which the droplet continued to expand represents 
the vaporization period. It was noted that the radius and interfacial velocity rapidly increased in 
the first 200 ns and the corresponding peak pressure was 70.5 pascal (Pa) in the envelope signal at 
184 ns when the droplet had the highest shell velocity and acceleration. In the subsequent 1 μs, the 
contracting process followed. During the period of 0.8 to 1.3 μs, PA signal was not detected since 
the shell radius remained nearly constant. The subsequent radius decreases contributed to another 
positive peak toward the tail of the signal. Approaching the end of contracting phase, a number of 
small daughter droplets were identified. The thin albumin shell of the droplet might have ruptured 
due to the vigorous dynamics of the contracting phase, which might have broken the symmetry of 
the droplet [86]. For the smaller droplet, the radius increased from 1.0 to 2.4 μm -approximately 
2.4 times. Peak pressure of the envelope signal was measured 7.8 Pa at 374 ns. In both cases, the 
predicted acoustic pressure compared reasonably well with the recorded pressure. As seen in Eq. 
2, acoustic pressure from the vaporization process is a function of the time-dependent radius, and 
its first and second time derivatives. For instance, a larger droplet and faster shell velocity during 
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vaporization should generate a larger PA signal. In Figure 12(c, f), a larger PA signal amplitude 
was detected from a larger droplet with the same laser input fluence. Therefore, if utilizing larger 
droplets under the same circumstances such as ambient pressure and temperature, a larger PA 
signal is expected when excited with the same laser fluence. However, droplets with larger 
diameters can become unstable. Some larger droplets (>7.5 μm) tended to grow continually into a 
giant gas bubble after undergoing a single vaporization and contraction event. Their instability 
must have prevented repetitive ODV. 
 
Figure 12. Selected frames of high-speed imaging at 5 million frames per second (a, d) and acoustic signal 
measurement (Red solid line in (c, f)) and theoretical estimation (Blue solid line in (c, f)) from shell 
dynamics of a large droplet (Diameter = 4.8 μm, (a-c)) and a small droplet (Diameter = 2.0 μm, (d-f)) with 
short pulse laser excitation. (5 ns duration, 800 nm wavelength). Laser was excited at 0 μs. Analytic pressure 
calculation was performed using Eq. 2 with radius-time curves (b, e) measured by high-speed optical 
imaging. 
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Figure 13 compares the repeatability and stability in response to the same laser exposure 
of two different size droplets, 2.0 and 7.7 μm. Figure 13(a) delineate the dynamics of a 2.0 μm 
droplet in response to consecutive laser excitations at different time points: prior (far left panel) 
and one-hour post exposure to six laser pulses (far right panel). Three snapshots are shown from 
each laser pulse at 0, 0.4 and 1.0 μs post excitation. The absence of apparent changes in size 
between pre- and post- multiple laser exposures indicates the stability of a 2.0 μm droplet. 
Corresponding PA signals were measured with similar amplitudes over each laser pulse, as 
similarly observed by others [77]. However, a droplet of 7.7 μm (Figure 13(b)) was so unstable 
that it grew continually into a giant gas bubble without contracting after a laser excitation. The 
bubble started to float away from the imaging plane at 1 second post excitation. Consistent 
observations (n = 5 at each size) from multiple experiments with droplets of similar sizes indicate 
that droplets less than 2-3 μm are more stable than larger ones of 4.5 μm or more. 
The high stability of these droplets formed in a micro- or nano-scale could be attributed to 
the increased boiling temperature from increased Laplace pressure which is inversely proportional 
to the size of the droplet as described by  
𝑃𝑃inside − 𝑃𝑃outside = 2𝜎𝜎𝑅𝑅                                                     (3) 
where Pinside is the pressure inside a droplet, Poutside is the ambient pressure, σ is the surface tension 
of the shell, and R is the droplet radius [76], [87]. For example, estimated vaporization 
temperatures of droplets with 1, 3, 5, 7, and 9 μm in diameter (Appendix B for more detail) are 
73.2, 49.5, 42.6, 39.3 and 37.3°C, respectively, for a given σ = 75 mN/m (at BSA concentration of 
2 mg/mL) [76], [87], [88]. As a result, micron-sized droplets (~9 μm) can remain in quasi-
superheated state without spontaneous vaporization at body temperature, because the Laplace 
pressure of the droplet is sufficiently high such that the boiling point is increased to above the 
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boiling temperature of the bulk liquid. Therefore, the size of droplets should be carefully selected 
for repeatable ODV. 
 
 
Figure 13. Repeatability of vaporization-recondensation and stability of droplet. (a) Optical (top panels) 
and acoustical (bottom panels) observations over 6 laser excitations on the same droplet measuring 2.0 μm 
in diameter at baseline. The envelopes of PA pressure were measured from multiple ODV processes of the 
same single droplet and corresponding high-speed images of each vaporization are shown in the top panel. 
Far left and far right panels depict droplets initially and 1 hour later, respectively. (b) Optical recording of 
a larger droplet (7.7 μm baseline diameter) over 1 second, imaged at lower frame rate. The vaporized droplet 
continually expanded after vaporization, and then floated away at 1 second. 
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Figure 14. Laser-induced vaporization of various sized droplets at different ambient temperatures. The 
snapshots at three different time points of 0.2 µs before laser excitation (left column), 0.6 µs after laser 
excitation (center column) and 2 µs after laser excitation (right column) during vaporization-recondensation 
processes below the bulk boiling temperature (20°C, top two rows) of PFP and above boiling temperature 
(37°C, bottom two rows) are depicted. Note that a laser pulse of 5 ns-long was induced at time 0 s over the 
circled area in green as shown in the left column. The dotted white circle identifies the droplet of interest 
located at the center of laser beam. The relatively large droplet (diameter of 7.9 µm) in a medium with 
temperature above the bulk boiling temperature of PFP did not recondense after vaporization. 
 
In order to study the effects of ambient temperature, droplets of 1-9 μm were exposed to a 
laser pulse when in the medium with controlled temperature above (37°C) or below (20°C) the 
bulk boiling temperature of PFP. The vaporization-recondensation dynamics of different size of 
droplets under different ambient temperatures in short (initial 2.2 µs) timescales were presented in 
Figure 14. The white dotted circle indicates droplets centered at the laser exposure spot illustrated 
in light-green circle. When the media temperature was below the boiling temperature, all of the 
droplets immediately shrunk back to their initial sizes following the ODV. However, large droplets 
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(>7 µm) grew continually after a brief contracting, and finally floated away from the field of view 
after 5 min. This transient contracting may be attributed to the partial recondensation of the 
vaporized PFP core and the diffusion of dissolved gas from surrounding medium into the liquid-
gas mixed droplet, as similarly shown in an acoustic droplet vaporization, and may have caused 
growing of the liquid-gas mixed droplet [89]–[94]. When the media was at temperatures above the 
boiling point of PFP, only small droplets (~2 µm) recondensed after vaporizing. Droplets larger 
than 3 µm grew continually with vigorous coalescences between neighboring vaporized droplets 
and eventually floated after 5 min without recondensation.  
 
Figure 15. Summary of observation and interpretation of experimental results. Each solid circle represents 
a measurement condition (n = 3, data binned with ± 0.5 µm). Recondensation was observed in blue colored 
droplets, and not observed in red colored droplets. Note each circle was scaled to the initial droplet size. 
*These droplets grew continually into a large gas bubble at later time. A droplet can be placed in three 
different states: (1) Vaporized (gas) or superheated state (liquid, light-red region), (2) Quasi-superheated 
state (liquid, light-blue or light-purple region), (3) liquid state (light-green region). The solid curve 
represents the size-dependent estimated boiling points of droplets as a reference threshold for vaporization. 
The dotted curve indicates the initial size of the droplets at each given temperature that can reach to the size 
on the solid curve at the same temperature after vaporization. Therefore, the droplets below the dotted curve 
will likely recondense, while those above will likely not reconsense after vaporization. 
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A summary of our observation and interpretation is illustrated in Figure 15. Each circle 
represents the baseline diameter of droplet on each experimental data point (n = 3). Color of the 
circle indicates whether recondensation after vaporization was observed (blue) or not (red). The 
solid curve represents the size-dependent increased boiling temperature of the droplet as a 
threshold for vaporization [76], [87], [88]. The dotted curve indicates the initial size of the droplets 
at each given temperature that can reach to the size on the solid curve at the same temperature after 
vaporization. The expansion ratio between liquid and gas was calculated using Eq. 3. The internal 
pressure, Pinside, was calculated using the ideal gas law combined with the conservation of mass 
between the initial droplet and the resulting bubble. Note that for this purpose, we assumed all PFP 
liquid contained in the droplet was fully vaporized. Therefore, the dotted curve separates the 
droplets that will likely recondense (below the dotted curve) from those that will likely not 
recondense after vaporization (above the dotted curve). A droplet can be placed in three different 
states, vaporized (gas) or superheated (liquid) state above the solid curve (light-red region), quasi-
superheated state (liquid) between the solid curve and the bulk boiling point of PFP (light-purple 
and light-blue region), and normal liquid state below the bulk boiling point of PFP (light-green 
region). 
 
3.4 CONCLUSIONS 
Overall, experimental results agree well with the theoretical estimation. Droplets that are 
relatively large tend to generate larger PA signals, but are likely unstable. Once vaporized, unstable 
droplets reacted in two different ways: some continue to grow without recondensing (red circle 
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with asterisk), while others continue to grow after transient contracting (blue circle with asterisk) 
likely due to partial recondensing of the PFP core. Conversely, stable droplets (blue circle without 
asterisk) that were relatively small exhibited multiple laser-induced vaporization-recondensation 
repeatedly with a relatively small PA signal amplitude compared to the large droplets. In addition 
to the effect of initial droplet size, stability would also be affected by ambient medium 
temperatures relative to the boiling temperature. Based on this consideration, a liquid core with a 
higher boiling temperature, such as perfluorohexane (C6F14, Boiling point of 56°C), may confer 
greater stability. In this study, thermodynamic aspects of the liquid-gas phase transition were not 
considered. Only droplet shell dynamics due to phase transition were studied in relation to resulting 
PA signal generation given fixed input laser fluence and core material. In order to further explore 
the underlying mechanism of ODV, a computational multiphase transition model must be 
developed. This developed model may foster more optimal design parameters of optically-
triggered droplets that include dye concentration, core materials, shell properties, as well as input 
laser fluence [41], [74], [95]–[101]. For further understanding of droplet dynamics under 
biologically relevant conditions such as body fluids or blood, viscosity of the medium also has to 
be considered [102]–[107].   
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4.0  PHOTOSTABLE, HYDROPHILIC, AND NEAR INFRARED QUATERRYLENE-
BASED DYES FOR PHOTOACOUSTIC IMAGING 
The work presented in this chapter was reprinted, with permission, from J.Yu, S. Pin, X. Lin, M. 
Bai and K. Kim, “Photostable, Hydrophilic, and Near Infrared Quaterrylene-based Dyes for 
Photoacoustic Imaging” that has been under reviewed.  
 
Novel near-infrared contrast agents based on quaterrylene structure were strategically 
developed and tested for high photo-stability. Both a dendrimeric quaterrylene molecule, QR-G2-
COOH, and a small molecule cationic quaterrylene dye, QR-4PyC4, remain optically stable and 
continue to generate competitive photoacoustic signal amplitude when irradiated by short near-
infrared laser pulses for a relatively long time in in-vitro cell study, unlike indocyanine green that 
rapidly decrease photoacoustic signal amplitude. The small molecule dye, QR-4PyC4 exhibits not 
only significantly higher cellular uptake rate than QR-G2-COOH and indocyanine green, but also 
low toxicity at concentration of up to 10 μM. The dendrimeric dye, QR-G2-COOH that has surface 
functional groups available for conjugation with targeting and therapeutic agents shows the highest 
photoacoustic amplitude with high optical stability. Therefore, QR-4PyC4 can be a promising 
universal, sensitive and reliable photoacoustic contrast agent and QR-G2-COOH has great 
potential as a nano-platform with stable photoacoustic imaging capability. 
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4.1 INTRODUCTION 
Photoacoustic (PA) imaging is a multi-wave imaging technology with a conversion from 
light energy to acoustic energy, exploiting both optical and acoustical characteristics. The PA 
signal generated from the thermo-elastic expansion of the tissue irradiated by a short-pulse laser is 
received by a ultrasound transducer, being able to provide optical contrast at ultrasonic imaging 
depth as complementary benefits from both technologies [108]. In efforts to enable PA imaging 
technology to detect biomarkers of interest with high sensitivity and specificity, several exogenous 
PA contrast agents, for example, organic dyes [109]–[111], carbon nanotube [112]–[114], gold 
nanoparticles [25], [115]–[119], and optically activatable phase-transition droplet [39], [40], [74], 
[120] have been developed. Some features as an ideal PA contrast agent include (1) a high molar 
absorption coefficient with low quantum yield at other than visible and infra-red (IR) region, 
preferably chosen in near-infrared (NIR) region, to maximize imaging depth and signal-to-noise 
ratio (SNR), because most endogenous optical contrast such as blood in vasculature [21], [43] and 
primary or metastatic melanoma [44] strongly absorb the visible or IR light [45], (2) high 
photostability which is necessary for a consistent long-term monitoring of biological activity 
progress under physiological environment in vivo [46], [47] and (3) high intracellular uptake or 
binding affinity, which determines functional or molecular selectivity. A common strategy is to 
conjugate targeting molecules to PA contrast agents to allow for specific binding to the target [42]. 
However, most current organic dyes used for PA imaging suffer from photobleaching or/and low 
cellular uptake [48], [49]. In addition, cell viability is an absolute prerequisite for practical 
usefulness just like for any other in vivo molecular imaging modality. For example, quantum dots 
(QD) has been studied as highly resisting to photobleaching with great PA contrast agent [50], but 
its toxicity prevents QD from being widely spread for in vivo imaging study.  
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In this study, to mainly overcome the poor photostability of most current PA contrast 
agents, we report two strategically designed agents based on the quaterrylene structure, a 
dendrimeric quaterrylene molecule (QR-G2-COOH) and a small molecule cationic quaterrylene 
dye (QR-4PyC4).  We choose the quaterrylene structure because our recent study suggests that 
quaterrylene-based agents can be highly photostable at NIR ranges [46]. Quaterrylene dyes have 
also been reported to have extremely high chemical stability as they can be heated to 570 °C 
without decomposition or melting [121]. PA contrast agents can be generally categorized into 
small-molecules such as dyes [122], [123], nanoparticles such as gold nanoparticles, carbon 
nanotubes and organic polymer nanoparticles [115], [124]–[126], and combination of both [116], 
[127]. Nanoparticles have high chemical, structural flexibility for incorporating targeting, 
signaling and therapeutic moieties and small molecules can easily pass through physiological 
barriers and get cleared quickly from biological systems [45]. For our newly developed PA contrast 
agent, the dendrimer represents a nanoplatform for PA imaging with surface functional groups 
available for conjugation with targeting and therapeutic agents to image/treat specific target of 
interest, and the small molecule cationic quaterrylene dye represents a universal PA agent, which 
is designed to provide high PA imaging intensity with high intracellular uptake efficiency that does 
not require a binding ligand to cell surface biomarkers. The generation-2 dendrimer (QR-G2-
COOH) is selected in this study, because lower generations (generation 1-2) show lower 
fluorescence quantum yield and therefore higher non-radiative conversion of light energy to heat 
to provide strong PA signal [42], while the QR-G2-COOH dendrimer still has sufficient surface 
carboxyl functional groups to allow for bioconjugation [128]. Moreover, both contrast agents are 
tuned to have strong absorption spectrum at NIR region of 650-850 nm, which is the preferably 
chosen PA imaging window in medical applications for low background endogenous molar 
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absorptivity, therefore maximum imaging depth and SNR [63], [111]. Photostability of both agents 
in a small tube is tested followed by an intracellular uptake experiment, comparing with a 
representative PA agent, Indocyanine green (ICG) that is the only NIR dye approved by Food and 
Drug Administration. 
4.2 MATERIALS AND METHODS 
4.2.1 Materials: Synthesis of QR-4PyC4 and QR-G2-COOH 
The solvents used are of commercial grade. The synthesis of QR-G2-COOH shown in 
Figure 16(a) was reported in our previous study [46].  The precursor of QR-4PyC4, QR-4Py shown 
in Figure 16(b), was synthesized by following our reported procedures [129].  Silica gel (standard 
grade, 60A, Sorbtech, Norcross, GA, USA) column chromatography was used to purify 
synthesized compounds. The 1H and 13C NMR spectra were recorded on the Brucker Avance III 
400 MHz instruments. UV/Vis spectra were recorded on a Cary 100 Bio UV-Vis 
spectrophotometer, and fluorescence spectra were recorded on a Cary Eclipse fluorescence 
spectrophotometer. The following instrument and reagent were applied in the cell viability 
evaluation: SynergyTM H4 Hybrid Multi-Mode Microplate Reader (BioTek, Winooski, VT, USA) 
was used for cell via, Zeiss Axio Observer fluorescent microscopy system (Zeiss, Jena, Germany), 
96-well optical black plates (Fisher Scientific, Pittsburgh, PA, USA), CellTiter-Glo Luminescent 
Cell Viability Assay kit (Promega, Madison, WI, USA). 
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Figure 16. (a) Chemical structure of QR-G2-COOH; (b) The precursor QR-4Py and the synthetic route of 
QR-4PyC4 
 
The precursor QR-4Py (12.5 mg, 9.4 µmol, Figure 16(b)) was heated at 110 °C in 
dimethylformamide (2 mL) under argon. 4-Methylbenzenesulfonate (1 mL, 4.9 mmol) was added 
and the resulting mixture was kept at 110 °C for 3 days. After the reaction mixture was cooled to 
room temperature, dimethylformamide was removed by rotary evaporation. The green solid was 
purified by dialysis (membrane cutoff = 1000) in methanol first and then in water for 2 days. QR-
4PyC4 (16 mg, 76 %) was obtained after being dried in lyophilizer. 1H NMR (400 MHz, d4-
MeOD, 25 °C, TMS): δ = 9.14 (s, 4 H), 9.07 (d, J = 8 Hz, 4 H), 8.61-8.65 (m, 8 H), 8.44 (s, 4 H), 
8.37 (d, J = 8 Hz, 4 H), 7.94-7.98 (m, 4 H), 7.53 (d, J = 8 Hz, 8 H), 7.46-7.50 (m, 2 H), 7.34 (d, J 
= 7.6 Hz, 4 H), 7.04 (d, J = 8 Hz, 8 H), 4.45 (t, J = 7.2 Hz, 8 H), 2.85 (sep, J = 6.8 Hz, 4 H), 2.20 
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(s, 12 H), 1.75-1.79 (m, 8 H), 1.12-1.14 (m, 32 H), 0.74 (t, J = 7.2 Hz, 12 H). 13C NMR (d4-
MeOD): δ =164.30, 157.32, 151.44, 147.19, 141.45, 141.08, 136.56, 134.73, 133.17, 131.82, 
131.36, 130.55, 130.04, 129.74, 128.09, 127.98, 127.76, 127.07, 126.81, 125.19, 123.82, 63.23, 
34.35, 30.30, 24.53, 21.25, 20.18, 13.76. 
 
4.2.2 Cell culture of MDA-MB-231 
MDA-MB-231 cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM, 
Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum (FBS, Fisher Scientific, 
Pittsburgh, PA, USA), and 1% Penicillin-Streptomycin-Glutamine (Life Technology, Carlsbad, 
CA, USA). Cells were incubated in a water jacketed incubator (37 °C, 5% CO2). 
 
4.2.3 Cytotoxicity evaluation of QR-4PyC4 
Cell viability was determined by CellTiter-Glo assay per the manufacturer’s instructions.  
The luminescent intensity was directly proportional to the amount of remaining viable cells. Cells 
were seeded into 96-well plates, incubated for 24 h, and then treated with QR-4PyC4 (0.1, 0.5, 1, 
5, 10, and 20 µM) for 6 hours.  Doxorubicin (DOX, 50 μM) was used as the positive (toxic) control. 
Cell medium was used as the negative (non-toxic) control. Cell viabilities were determined by 
recorded luminescent intensity in each group over that of the vehicle group. 
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4.2.4 Cellular uptake study 
The cell uptake of ICG, QR-G2-COOH and QR-4PyC4 were evaluated in MDA-MB-231 
cells, which were seeded onto 96-well plates and incubated for 24 h before treatment. The cell 
uptake of ICG was measured by fluorescence. The fluorescence intensities were recorded using a 
plate reader (excitation/emission 750/820 nm). Cells were treated with ICG (10 µM) and then 
divided into two groups (4 wells/group): experiment group was washed with PBS once to remove 
extracellular ICG and control group was used without wash. The cell uptake of ICG was calculated 
as the ratio of the fluorescence intensity of the experiment group to that of the control group. 
The cell uptake of QR-G2-COOH and QR-4PyC4 was evaluated using modified extraction 
method [130]. To account for the low fluorescence signal from QR-G2-COOH and QR-4PyC4 
upon irradiation, we used absorption to quantify the cell uptake, instead of fluorescence. Cells 
were divided into 3 groups (4 wells/group). The experiment group, control group, and the third 
group was used for absorption background calibration. The medium in the control and background 
groups was removed gently, and 10 µM of dye (QR-G2-COOH or QR-4PyC4) in DMSO and pure 
DMSO were added, respectively, followed by absorption measurement. For the experiment group, 
cells were treated with dye (10 µM) in cell medium for 6 h, washed with PBS once and DMSO 
was added to extract intracellular dye molecules for absorption measurement. Raw absorption 
values were recorded using a plate reader, and true absorption values were obtained after 
subtracting the background reading. The cell uptake is calculated as the ratio of the absorption 
intensity of the experiment group to that of the control group. 
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4.2.5 Photoacoustic imaging and bright-field imaging 
Acoustic-resolution photoacoustic microscopy system was utilized for all this study to 
acquire PA images (Figure 17). A tunable laser system with an optical parametric oscillator (OPO, 
Vibrant HE532I, OpoTek, Carlsbad, CA, USA) pumped by Q-switch Nd: YAG pulsed Laser 
(Quantel, Bozeman, MT, USA) generates a short pulse of 5 ns long at pulse repetition frequency 
of 10 Hz. The pulse laser wavelength is tuned at 740 nm to have similar absorption coefficients 
for QR-4PyC4 and QR-G2-COOH. The collimated laser beam was focused by a concave lens and 
then illuminated onto the target. Target can be moved by dual-axis motorized translational stage 
(T-L SR150B, Zaber, Vancouver, BC, Canada) for raster scanning.  The excited laser energy was 
monitored using an energy meter (EnergyMax, J-50MB-YAG, Coherent, Santa Clrara, CA, USA). 
Measured laser pulse fluence is approximately 22 mJ/cm2, satisfying the American National 
Standards Institute safety guideline for laser use (ANSI, Z136.1). A focused single element 
ultrasonic transducer (V375, f0 = 30 MHz, Olympus NDT, Waltham, MA, USA) was employed to 
detect the PA signal. Received PA signal was amplified (5900PR, Olympus NDT, Waltham, MA, 
USA), and then digitized by an oscilloscope (WaveSurfer 452, LeCroy, Chestnut Ridge, NY, 
USA). Laser excitation system and data acquisition system were synchronized.  
Figure 17. Acoustic-resolution photoacoustic microscopy setup for cell study. UT: Single element 
focused ultrasound transducer (f0 = 30 MHz) 
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A lowpass filter (cut-off bandwidth: 45 MHz) was applied to the raw RF PA signal, and 
then its envelope was extracted using the Hilbert-transform to generate a PA image. For 
photostability study, PA signal amplitudes were continuously measured from the polyethylene 
tube (PE-50, Inner diameter: 580 µm; Outer diameter: 965 µm, BD intramedic, Franklin Lakes, 
NJ, USA) filled with the diluted dye solution at 10 µM. For cell study, cell treated with each dye 
on the slide was located on the slide holder. The scan area was about 3.2 mm length by 2.4 mm 
width with 400 µm step size. The diameter of the irradiation beam size is larger than this area to 
provide the uniform light illumination. The PA signal was averaged three times at each scanning 
grid point to minimize the pulse-to-pulse energy variation and to increase the signal to noise ratio. 
The maximum amplitude projection and log-compression were applied to the filtered data. All 
signal processing was performed offline using MATLAB software. For verification purpose, cell 
locations were derived as a ground truth for PA image. Raster scanned multiple bright-field images 
by using inverted microscope (IX-81, Olympus, Center Valley, PA, USA) were stitched to form 
single image. To select only nuclei on the image, image contrast was adjusted higher, and then 
local maxima represented in green dots with proper threshold was derived by using ImageJ 
software. The image of localized cells was overlaid on the PA image for comparison 
4.3 RESULTS AND DISCUSSIONS 
4.3.1 Dendrimer characterization 
Dendrimers provide a superior nanoplatform due to their precisely controlled size, shape, 
and surface chemistry. These unique properties allow dendrimers to be developed with high 
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structural mono-dispersity, desired plasma circulation time and bio-distribution properties, as well 
as control over drug release. In addition, targeting moieties can be attached to the surface 
functional groups of dendrimers to allow targeted drug delivery, and signaling molecules can be 
attached to monitor drug delivery, release, and efficacy. We recently reported a series of 
quaterrylene-based dendrimers for fluorescence imaging [46]. We found that these quaterrylene-
based dendrimers are biocompatible and show intense NIR absorption, with remarkable chemical 
and photostability. Importantly, the low generation quaterrylene-based dendrimers show minimal 
fluorescence quantum yield; therefore, it may generate strong PA signal. In this study, we choose 
the second generation, QR-G2-COOH (Figure 16(a)), to evaluate the potential in PA imaging. In 
addition to QR-G2-COOH, we also synthesize a small molecule quaterrylene dye, QR-4PyC4 
(Figure 18(b)). The design of QR-4PyC4 has several features: (1) the quaterrylene structure offers 
intense NIR absorption; (Figure 18(a)) (2) high hydrophilicity due to charges; and (3) four positive 
charges for strong binding to mitochondria membrane. Recent studies have suggested that 
mitochondria increase in size and number in malignant cells [131]. Therefore, these features 
qualify QR-4PyC4 as a universal PA agent for cancer imaging without the need of targeting 
ligands.  
Figure 18. Optical characteristic and photoacoustic response of QR-4PyC4, QR-G2-COOH, and ICG dyes. 
(a) Absorption spectrums of QR-4PyC4 (blue solid line), QR-G2-COOH (black solid line), and ICG (red 
solid line) in PBS solution at 10 µM concentration. (b) Change of PA signal amplitude at 740 nm of QR-
4PyC4 (blue solid line), QR-G2-COOH (black solid line), and ICG (red solid line) over 3,600 short-pulse 
laser exposures. Each data point represents an average over 5 measurements and error-bars are shown every 
60 points.
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As shown in table 2, QR-G2-COOH and QR-4PyC4 exhibits relatively intense absorption 
in the NIR region in PBS, although their molar extinction coefficients (ε=0.52 and 0.66 x 105cm-
1M-1 for QR-G2-COOH and QR-4PyC4 in PBS respectively, as compared to ε=2.45 x 105cm-1M-
1 for ICG) are lower than that of ICG, which is likely ascribed to the significant aggregation of 
quaterrylene rings at high concentration of 10 μM. Importantly, both QR-G2-COOH and QR-
4PyC4 are much less fluorescent than ICG at the same concentration (Figure 19, Table 2).  
Figure 19. Fluorescence spectra of ICG, QR-G2-COOH and QR-4PyC4 at 10 µM 
As a result, the energy decay mechanism of ICG has two major contributions: non-radiative 
and radiative, whereas the excited QR-G2-COOH and QR-4PyC4 molecules mainly decay through 
non-radiative pathway, light to heat energy conversion that produces PA signal [128]. 
Table 2. The photophysical properties of ICG, QR-G2-COOH and QR-4PyC4 at 10 μM PBS solution. 
10 μM in PBS 
λabs/nm (ε/105cm-1M-1) λem/nm 
QR-G2-COOH 734 (0.52) -- 
QR-4PyC4 743 (0.66) -- 
ICG 777 (1.08); 699 (1.15) 804 
--: too weak to be detected. 
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4.3.2 Photostability evaluation 
We first carried out photobleaching test in a polyethylene tube to evaluate the photostability 
of QR-4PyC4, QR-G2-COOH and ICG. PA signal amplitudes at 740 nm were measured from each 
dye over continuous 3,601 laser excitations of 22 mJ/cm2 (Figure 18(b)). Normalized PA signal 
amplitudes of ICG, QR-G2-COOH, and QR-4PyC4 at the first laser excitation are 1.5, 1.2, and 
0.6, respectively, among which the difference is expected from the absorption spectrum of those 
dyes (Figure 18(a)). After being exposed to continuous laser irradiation for 300 shots, however, 
PA signal amplitude of ICG dramatically decreases by 66.7% and corresponding SNR is changed 
from 37.4 dB to 27.8 dB, while PA signal amplitude of QR-4PyC4 and QR-G2-COOH only 
decreases by 13.1% and 4.7%, respectively, and corresponding SNR is changed from 33.0 dB to 
31.8 dB and from 36.6 dB to 36.2 dB, respectively. After additional 3,300 shots, PA response of 
QR-4PyC4 becomes stable as a PA signal amplitude changes in only 1.1%, and corresponding 
SNR drops from 31.8 dB to 31.7 dB, while PA signal amplitude for QR-G2-COOH and ICG 
continually decreases by 13.7% and 16.1%, respectively, and corresponding SNR drops from 36.2 
dB to 34.9 dB and from 27.8 dB to 26.3 dB, respectively. These results indicate that the developed 
dendrimer dyes, QR-4PyC4 and QR-G2-COOH, retaining with high photostability with 
competitive PA signal generation efficiency over a total of 3,601 laser shots 
4.3.3 Cellular uptake and viability test 
To demonstrate the high cellular uptake of QR-4PyC4, we compared uptake of QR-4PyC4, 
QR-G2-COOH and ICG in MDA-MB-231 cells. We observe as high as 13% cell uptake of QR-
4PyC4 (3.2-fold higher than QR-G2-COOH), as compared to 4% for QR-G2-COOH and 1% for 
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ICG (Figure 20). As we discussed above, the four positive charges on QR-4PyC4 allows for strong 
binding to mitochondria membrane, therefore, high cellular update is expected. It’s not surprising 
that QR-G2-COOH also shows higher uptake than ICG because it has been reported that 
nanostructures are prone to endocytosis by cells [132]. 
 
Figure 20. Cellular uptake percentage of QR-4PyC4, G2-QR-COOH, and ICG dyes. 
As the following study, cell viability was evaluated after treating with QR-4PyC4 dye that 
has superior photostability and intracellular uptake characteristics. Our cytotoxicity study shown 
in Figure 21 suggests that most cells treating with QR-4PyC4 at the concentration of up to 10 µM 
can survive. Low cytotoxicity of QR-G2-COOH has been reported in the our previous study [46]. 
 
Figure 21. Cell viability of QR-4PyC4 in MDA-MB-231 cells. Cell medium (Dye concentration at 0 μM) 
was used as a negative control, non-toxic, and, Doxorubicin (DOX) was used as a positive control, toxic. 
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4.3.4 Photoacoustic imaging of MDA-MB-231 using QR-4PyC4, QR-G2-COOH, and ICG 
In Figure 22, the PA signal intensity map (Figure 22(b)) is compared with the cell 
distribution shown in the wide-view bright field microscopy image (Figure 22(a)) that is stitched 
from individual microscopy images. Green dots that indicate each cell locations in microscopy 
image (Figure 22(a)) are overlaid on PA image (Figure 22(b)) for presentation purpose of 
comparison. While the cells could not be individually identified in PA image due to the limited 
spatial resolution of the ultrasound transducer (Theoretical beam diameter: 167 μm @ -6 dB 
bandwidth), PA signal amplitude would be expected to be proportional to cell distribution within 
the focal region of ultrasound transducer and it is well shown in Figure 22. 
 
 
Figure 22. (a) Optical microscopy image (10x) and (b) Photoacoustic image of MDA-MB-231 cells with 
QR-4PyC4 dye overlaid on microscopy image. Cells are marked as green spots. PA signal intensity is 
directly proportional to cell confluence. 
 
In order to evaluate the photostability of the dye, three PA images were sequentially 
acquired from MDA-MB-231 cells treated with QR-4PyC4, QR-G2-COOH, and ICG as depicted 
in Figure 23.  
 58 
 
Figure 23. Photoacoustic image of MDA-MB-231 cells stained with QR-4PyC4, QR-G2-COOH, and 
ICG. Images in each column are subsequently acquired. 
 
Averaged PA signal amplitude on each image was shown in Figure 24. Interestingly, PA 
signal amplitude averaged on the ROI from QR-4PyC4 dye shows higher amplitude (30.0±0.7 dB) 
than signal amplitudes from the other two dyes (QR-G2-COOH: 8.6±3.4 dB, ICG: 11.1±3.5 dB) 
at the 1st scanning. PA signal from QR-G2-COOH shows the lowest value in the cell study 
although absorption coefficient and PA signal amplitude of QR-G2-COOH shows the highest 
values in vitro. This is mainly attributed to lower cell uptake efficiency of QR-G2-COOH dyes 
compared to QR-4PyC4 dye due to its large molecular structure. Reflecting the signal drop by 
photobleaching, averaged PA signal amplitude decreases by 5.6% (from 30.0±0.7 dB to 29.5±1.1 
dB) for QR-4PyC4, 16.1% (from 8.6±3.4 dB to 7.1±3.2 dB) for QR-G2-COOH, and 17.7% (from 
11.1±3.5 dB to 8.4±6.0 dB) for ICG between 1st and 2nd scanning. In the following 3rd scanning, 
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PA signal from QR-4PyC4 and QR-G2-COOH does not decrease as much as initial signal drop by 
only 0% (from 29.5±1.1 dB to 29.5±1.3 dB) and 1.1% (from 7.1±3.2 dB to 7.0±3.3 dB), 
respectively, but PA signal from ICG continue to decrease by 12.9% (from 8.4±6.0 dB to 7.2±5.0 
dB). Looking at the entire scanning period, averaged PA signal amplitude decreases by 5.6% (from 
30.0±0.7 dB to 29.5±1.3 dB) and 16.8% (from 8.6±3.4 dB to 7.0±3.3 dB) for QR-G2-COOH, and 
36.2% (from 11.1±3.5 dB to 7.2±5.0 dB) for ICG, between the 1st scanning and 3rd scanning. In 
summary, while PA signal from ICG continually decreases as scanning trial increases, PA signals 
from QR-4PyC4 and QR-G2-COOH dyes retains stable level after a decrease during the initial 
scanning. 
 
Figure 24. Averaged PA signal amplitudes of MDA-MB-231 cells stained with QR-4PyC4, QR-G2-
COOH, and ICG. 
 
These overall trends shown in Figure 24. are well-matched with in vitro photostability 
measurement shown in Figure 18(b). Note that the cells were exposed to the laser light in multiple 
times during each raster scan due to the laser beam (3 mm in radius, 28.3 mm2 in area) is bigger 
than the scanning step size of 400 μm. All these results suggest that QR-4PyC4 could be potentially 
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used for long-term PA monitoring of the biological activities due to its high photostability and cell 
uptake efficiency. After modification with some special moieties, such as ligand and drug, QR-
G2-COOH could also be utilized for long-term PA monitoring, thus permitting the application of 
different imaging modalities and therapeutic strategy. Due to lack of the efficient laser exposure 
system for several days continuously, this study is limited to evaluate their photostability by using 
only short and strong laser pulses within limited time. However, we have expected that the 
quaterrylene dyes keeps its photostability against more light exposures over several days. Based 
on our experience, these dyes can be stored under the room light for several months without 
significant loss of PA imaging capability. In future work, the photostability of our developed 
quaterrylene structure dyes will be quantitatively evaluated day-by-day to extend the timeline 
limitation of this study with more systemic designed experimental system 
4.4 CONCLUSION 
Both QR-4PyC4 and QR-G2-COOH show significantly high photostability as compared 
to ICG, which makes them strong candidates of reliable PA agents for a long-term imaging.  While 
overall PA signal intensity from QR-G2-COOH is higher, cell uptake rate of QR-4PyC4 is found 
superior to QR-G2-COOH and ICG. Due to the superior photostability, cell uptake, and cell 
viability, this study suggests that QR-4PyC4 is a promising candidate as a universal, sensitive, and 
reliable PA agent and QR-G2-COOH has potential as a nano-system with its high structural 
flexibility for PA imaging. 
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5.0  SUPER-RESOLUTION ULTRASOUND IMAGING WITH HIGH TEMPORAL 
RESOLUTION: IN VIVO FEASIBILITY ON VASA VASOROM IN 
ATHEROSCLEROSIS RABBIT MODEL 
The work presented in this chapter was reprinted, with permission, from J.Yu, L. Lavery and K. 
Kim, “Super-resolution ultrasound imaging with high temporal resolution: In vivo feasibility on 
vasa vasorum in atherosclerosis rabbit model” that was submitted and under reviewed.  
 
Traditional ultrasound imaging techniques are limited in spatial resolution to visualize 
angiogenic vasa vasorum that is considered as an important marker for atherosclerotic plaque 
progression and vulnerability. The recently introduced super-resolution imaging technique based 
on microbubble center localization has shown potential to achieve unprecedented high spatial 
resolution beyond acoustic diffraction limit. However, a major drawback of the current super-
resolution imaging approach is low temporal resolution because it requires a large number of 
imaging frames. In this study, a new imaging sequence and signal processing approach for super-
resolution ultrasound imaging are presented to improve temporal resolution by employing 
deconvolution and spatio-temporal-interframe-correlation based data acquisition. In vivo 
feasibility of the developed technology is demonstrated and evaluated on vasa vasorum in the 
rabbit atherosclerosis model. The proposed method not only identifies a tiny vessel with diameter 
of 41 μm, 5 times higher spatial resolution than the acoustic diffraction limit at 7.7 MHz, but also 
significantly improves temporal resolution that allows for imaging vessels over cardiac motion. 
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5.1 INTRODUCTION 
Acute coronary syndromes (ACS), a leading cause of morbidity and mortality in the US 
and Europe, is generally caused by the plaque rupture or erosion [133]–[136]. Extensive efforts to 
characterize and predict vulnerable plaques assessing a few known markers have been made for 
several decades [133]–[139]. It has been found that abnormally dense neovascularization of the 
vessel wall, often infiltrating into the plaque core, is associated with development of 
atherosclerotic plaque and progression of the disease [136], [140]. These micro-vasculatures may 
lead to intraplaque hemorrhage, which typically accompanies unstable plaque [136], [140], [141]. 
Therefore, abnormal proliferation of adventitial vasa vasorum (VV) is an important clinical 
imaging target to assess vulnerability of the atherosclerotic plaques [136]–[140], [142]. However, 
the lack of adequate noninvasive and high-resolution imaging technology to visualize VV is a big 
challenge. Micro-CT, optical coherent tomography (OCT) and contrast enhanced ultrasound 
(CEU) imaging have been demonstrated to image VV in pre-clinical studies, but these technologies 
have suffered from hazardous radiation (micro-CT), poor imaging depth (OCT), and insufficient 
spatial resolution (CEU) [137], [138], [143]–[145]. 
CEU is one of well-established imaging modalities to evaluate microvasculature in vivo 
animal study using gas-filled microbubbles that can provide high echogenic contrast [138], [145], 
[146]. In previous studies with CEU using a mid-frequency linear array transducer (Transmit at 7 
MHz and receive at 15 MHz), they have shown the correlation of adventitial VV density based on 
ultrasonic image intensity with VV progression [138], [145], [146]. However, identifying VV, 
especially those near the lumen of the main vessel, at mid-frequency was limited mainly due to 
low spatial resolution [138]. Because of this limitation with spatial resolution, accuracy of VV 
density  measure therefore was limited. High spatial resolution is essential for separating individual 
 64 
tiny VV from the lumen of the main vessel to improve accuracy of adventitial VV density as an 
indicator of VV progression. A high-frequency ultrasound transducer that can provide spatial 
resolution of 35-40 µm at center frequency higher than 30 MHz might be able to identify VV in 
vivo, but it is preferably utilized in intravenous approach due to its limited imaging depth less than 
2 cm. This approach is not ideal if considering eventual translation with full noninvasiveness. 
Therefore, transcutaneous imaging approach using a mid-frequency transducer commonly used in 
clinic would be sought after. 
Super-resolution US imaging technology has been recently introduced to overcome the 
limitation of inherent spatial resolution of US imaging defined by the acoustic diffraction limit 
[51], [52]. This approach utilizes two state-of-the-art technologies; tissue rejection and 
microbubbles localization technique [51], [54], [56], [147]. It is known that ultrafast plane wave 
imaging in general significantly improves the performance of the eigen decomposition based 
adaptive clutter filtering technique, outperforming in suppressing stationary signal that comes from 
the clutter component, compared to conventional clutter filtering techniques used in typical 
Doppler imaging[56]. Moreover, microbubble center localization technique allows to estimate 
each location of  microbubbles in sub-pixel level precision [51], [54], [147]. Each microbubble 
could be considered as a point source because its size (~3 µm) is much smaller than the spatial 
resolution of the imaging system that operates at mid-frequency ultrasound of around 5 - 10 MHz 
(100~200 µm). Therefore, received echo signal from individual microbubble would be represented 
as a point spread function (PSF) of the imaging system, and each microbubble is expected to be 
located at the centroid of the PSF. After summing up localized microbubbles in blood flow over a 
large number of frames, a vascular network image in high spatial resolution beyond the acoustic 
diffraction limit can be formed. Errico et al., successfully reconstructed single static super-resolved 
 65 
image of rat brain vasculature network, identifying the micro-vessel in diameter as small as 9 μm 
full-width at half-maximum (FWHM) with using a 20 MHz linear array transducer [51]. However, 
the major drawback of this method requires a long data acquisition time of 150 seconds for a total 
of 75,000 frames at 500 frames per second. Requiring a long data acquisition time makes this 
imaging technology susceptible to target motion and therefore hinders widespread of this 
technology for various applications.  
Here, we present a new approach of super-resolution US imaging technology to achieve a 
high temporal resolution as well. A strategically designed approach in two steps is employed to 
drastically improve temporal resolution; 1) deconvolution localization technique to reduce data 
acquisition time, and 2) spatio-temporal-interframe-correlation (STIC) based data acquisition to 
compensate motion over reduced data acquisition time. First, applying deconvolution separates 
each center of microbubbles from densely grouped microbubbles while previous approach, 2D 
Gaussian fitting, typically requires discarding such frames in which clumped microbubbles cannot 
be separated. Therefore, deconvolution technique can significantly reduce data acquisition time. 
However, reduced data acquisition time using deconvolution only is not short enough to ignore 
fast physiologic motion such as cardiac-dependent motion. In addition to deconvolution technique, 
therefore, STIC data acquisition inspired from 3D fetal echo-cardiology imaging technique is 
adapted to further overcome fast physiologic motion [148]. STIC acquisition allows it to 
synchronize collected images over multiple cardiac cycles. In vivo feasibility of the developed 
technique in identifying VV is demonstrated in rabbit atherosclerotic plaque model. 
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5.2 MATERIALS AND METHODS 
5.2.1 Deconvolution-based super-resolution US imaging sequence 
Super-resolution imaging sequence was implemented into a fully-programmable 
ultrasound scanner (Vantage 128, Verasonics, Kirkland, WA, USA) equipped with a high 
frequency hockey stick linear array transducer centered at 8.8 MHz (CL15-7, ATL-Philips, 
Bothell, WA). 
 
 
Figure 25. Block diagram for signal processing of super-resolution ultrasound imaging. BF: Delay-and-
sum beamformer; QD: Quadrature demodulator; CF: Eigen-based spatio-temoral clutter filter; ED: 
Envelope detector; DV: Deconvolution with the system PSF; ∑: Integrator with STIC data alignment based 
on estimated cardiac pulsation. 
 
Ultrasound plane waves were insonified to the target with high pulse repetition frequency (PRF) 
of 1,500 Hz with three different steering angles (-3°, 0°, 3°) for compounding, therefore the 
effective PRF is 500 Hz. Signal processing algorithm was illustrated in Figure 25. Acquired raw 
radio-frequency (RF) channel data were beamformed by delay-and-sum algorithm, and then 
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downmixed to the baseband using a quadrature demodulator. The echo signal from microbubbles 
were extracted from compounded analytic baseband signal of 500 frames by using a spatio-
temporal eigen-based decomposition clutter filter[56], [149], [150]. Envelope of the echo signal 
from microbubbles was interpolated for an increased pixel resolution of 15 µm (lateral) × 10 µm 
(axial) and deconvolved with the measured system PSF to localize each microbubble. Richardson-
Lucy (RL) deconvolution is a non-linear iterative deconvolution method that has been widely used 
for deblurring image with the presence of Poisson distributed noise in astronomy and biomedical 
applications[57], [151]–[153]. The iterative process is described by 
𝑖𝑖(𝑘𝑘+1) = 𝑖𝑖(𝑘𝑘) �ℎ ∗ 𝑔𝑔
ℎ ⨂ 𝑖𝑖(𝑘𝑘)� 
where, * is the correlation operator, ⨂ is the convolution operator, i(k) is the estimated image after 
k iterations, h is the PSF of the imaging system and g is blurred image modeled by 𝑔𝑔 = ℎ⨂𝑖𝑖(0) +
𝑛𝑛𝑛𝑛𝑖𝑖𝑛𝑛𝑛𝑛[153].  The concept of this approach is illustrated in Figure 26. 
The echo signal received by the imaging system (Figure 26(c)) is represented by 
convolving the PSF of the imaging system (Figure 26(a)) with two point targets (Figure 26(b)). 
Figure 26(c, e) shows the received signal (indicated by ‘Overall’) from two targets separated by 
70 μm, smaller than the spatial resolution of the system. With using deconvolution (#s of iteration 
= 100), however, this signal can be separated into two different targets as shown in Figure 26(d, 
f). A potential problem with the RL deconvolution algorithm is noise amplification, which is 
known to be generic for all maximum likelihood techniques. Therefore, any false target can be 
expected when signal-to-noise ratio is not high enough due to noise-sensitive RL deconvolution. 
For example, in Figure 26(e, f) deconvolving the received signal from two targets with significant 
Gaussian white noise resulted in imperfect target locations. This high sensitivity to noise can be 
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alleviated with several available standard regulation approaches. In this study, thresholding at -10 
dB was applied to pre-deconvolved signal to suppress noise component. 
 
 
Figure 26. Conceptual demonstration of sub-wavelength localization using deconvolution on synthetic 
data. (a) PSF of imaging system. FWHM is assumed as 150 µm. (b) The locations of the two neighboring 
targets. Two targets are positioned 70 µm apart. (c) Synthetic signal received from two targets is shown in 
(b) using the imaging system with PSF shown in (a). Two targets cannot be separated in the image due to 
their distance is shorter than the spatial resolution of imaging system. (d) Deconvolution results of received 
signal shown in (c) using the system PSF shown in (a). Two targets are distinctly identified. (e) Synthetic 
signal received from two targets when noise is added is shown in (b) using the same imaging system. (f) 
Deconvolution results of (e), where two targets are clearly identified with minimal interference due to noise 
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5.2.2 Spatio-Temporal-Interframe-Correlation (STIC) based data re-alignment algorithm 
STIC data re-alignment algorithm that synchronizes among collected cardiac cycles based 
on estimated cardiac pulsation is developed to monitor fast physiological event under limited 
imaging speed. To capture rapid physiological dynamics at a limited frame rate, sequentially 
acquired RF data over multiple cardiac cycles can be synchronized based on the cardiac cycle 
period estimated from the periodically changing signal intensity, which reflects the number of 
microbubbles. Rigid motion in frame-by-frame caused by respiratory or operator dependent 
motion was compensated by applying an offset to match acquired images. Offset was estimated 
by taking 2-dimensional cross-correlation between frames. If correlation coefficient between 
images is smaller than 0.9, the image can be excluded. The eigen-based spatio-temporal tissue 
rejection filter technically removes all stationary tissue information except for moving objects, 
such as microbubbles. At diastolic phase, microbubbles are less likely flow, therefore smaller 
number of moving microbubbles are detected. On the contrary, the number of detected 
microbubbles significantly increases as microbubbles are moving fast toward the systole. Low-
pass filter is applied to the detected signal from flowing microbubbles to estimate the cardiac 
period. Figure 27 illustrates an example of the number of detected microbubbles as a function of 
time (blue solid line) over 2 seconds totaling 1,000 data points. The reference frame for 
synchronization (red solid line) was chosen at the minima after low pass filtering. The estimated 
period of 5 Hz by this approach has good agreement with the heart rate recorded by 
electrocardiogram of 290-310 beats per minute. 
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Figure 27. Estimated cardiac pulsation by counting the numbers of flowing microbubbles (blue solid line). 
After applying low-pass-filtering, the frames with minimum value are chosen as reference frames for 
synchronization (red solid line) 
 
Figure 28 shows overall graphical diagram of STIC acquisition method. First, we collected 
raw ultrasound RF data sequentially over multiple cardiac cycles. Acquired US frames are 
synchronously aligned based on cardiac period estimated by the numbers of microbubbles. Re-
aligned images are integrated to form a super-resolution image of single cardiac cycle. In this 
study, we collected continuous 3,000 frames over 6 seconds, which is equivalent to approximately 
15-30 cardiac cycles. Each cardiac cycle was divided by 10 sections and entire dataset was aligned 
based on section number. Aligned frames in each section were summed to reconstruct single super-
resolution frame. Therefore, single cardiac cycle containing 10 reconstructed frames with super-
resolution was generated and each super-resolution image contains around 300 acquired frames 
collected over multiple cardiac cycles. 
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Figure 28. Graphical diagram of STIC data acquisition. Sequentially acquired multiple datasets are 
synchronized to form single cardiac cycle event based on the cardiac pulsation estimated by the numbers 
of bubbles. 
5.2.3 Rabbit atherosclerotic plaque model 
A New Zealand white rabbit (3.5 kg) was fed a high fat and cholesterol diet (cholesterol 
1%, peanut oil 2.5%, and fat 10%) over 6 weeks to accelerate development of atherosclerosis[138]. 
Balloon injuries were induced to the superficial femoral artery on the right side of an anaesthetized 
rabbit (ketamine 150 mg IM, xylazine 8 mg IM and 2.5% inhaled isofluorane) by using a 2F 
Fogarty balloon catheter (Edwards Life Sciences, CA, USA) one-week after feeding. The balloon 
inflated at 2 atm was moved back and forth several times to apply injury to the vessel walls around 
bifurcation area under guidance of high-frequency ultrasound scanning (Vevo2100 equipped with 
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a linear array transducer centered at 18.5 MHz, FUJIFILM Visualsonics, Toronto, On, Canada). 
Upon completion of imaging, blood of 5 mL was obtained to measure cholesterol concentration. 
 
5.2.4 Ultrasound imaging protocol 
At twelve weeks after surgery, ultrasound imaging were performed injecting a commercial 
microbubbles (Definity, Lantheus Medical Imaging, N. Billerica, MA). A 0.2 mL microbubbles 
bolus was intravenously administrated through an ear vein access catheter for each imaging session. 
An anaesthetized rabbit (same protocol of surgery) was prepared with hair-shaved legs (Figure 29). 
US gel was applied for ultrasonically coupling. Super-resolution US imaging sequence was 
performed to the surgical side and thereafter contralateral side by using a fully programmable 
research ultrasound scanner (Vantage 128, Verasonics, Kirkland, WI) equipped with a hockey 
stick linear array transducer (CL15-7, ATL-Philips, Bothell, WA). A transducer holder was used 
to fix the transducer. Compounded plane wave images with 3 different angles of total 9,600 frames 
were acquired in each data acquisition. To verify repeatability, total three datasets were collected 
on the possibly same imaging plane. All signal processing was performed offline using MATLAB 
software (Mathworks, Natick, MA). Harmonic MIP imaging was sequentially conducted on the 
same location by using a commercial ultrasound imaging equipped with a linear array transducer 
(Acuson Sequoia 512 with 15L8, SIEMENS, Mountain view, CA). To quantify degree of vasa 
vasorum development, vessel density was calculated by  
𝑉𝑉𝑉𝑉𝑛𝑛𝑉𝑉 𝑉𝑉𝑉𝑉𝑛𝑛𝑛𝑛𝑟𝑟𝑉𝑉𝑉𝑉 𝑑𝑑𝑛𝑛𝑛𝑛𝑛𝑛𝑖𝑖𝑡𝑡𝑑𝑑 = 𝑛𝑛𝑖𝑖𝑔𝑔𝑛𝑛𝑉𝑉𝑠𝑠 𝑖𝑖𝑛𝑛𝑡𝑡𝑛𝑛𝑟𝑟𝑛𝑛𝑛𝑛𝑖𝑖𝑡𝑡𝑑𝑑 𝑛𝑛𝑛𝑛 𝑉𝑉𝑑𝑑𝑎𝑎𝑛𝑛𝑛𝑛𝑡𝑡𝑖𝑖𝑡𝑡𝑖𝑖𝑉𝑉 𝑉𝑉𝑟𝑟𝑛𝑛𝑉𝑉
𝑉𝑉𝑑𝑑𝑎𝑎𝑛𝑛𝑛𝑛𝑡𝑡𝑖𝑖𝑡𝑡𝑖𝑖𝑉𝑉 𝑉𝑉𝑟𝑟𝑛𝑛𝑉𝑉  
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where, adventitia area was manually selected on the B-mode. Above in vivo surgery and imaging 
protocols of rabbit were approved by Institutional Animal Care and Use Committee (IACUC) of 
University of Pittsburgh. 
 
Figure 29. Experiment setup of rabbit imaging. Microbubbles were injected via ear vein access. A hockey 
stick linear array ultrasound transducer was used for imaging. Transducer holder is used to remove operator-
dependent motion in this study 
 
5.2.5 Histology and Immunofluorescence 
Femoral arteries were perfusion fixed using paraformaldehyde, and then carefully excised 
along with a block of the surrounding muscle to save neighbor vasculature in the connective 
tissues. Excised tissues were then carefully fixed in 4% paraformaldehyde, embedded in the 
paraffin-block and serially sectioned. Cross-sections of the paraffin block were stained with 
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hematoxylin and eosin (H&E) and Von Willebrand Factor (vWF) for endothelium staining. In 
briefly, for antigen retrieval, treatment dewaxed slides were heated in sodium citrate buffer (pH 
6.0, abcam, Cambridge, MA) at 95°C for 30min in blocking solution of goat serum and incubated 
with the anti-vWF antibody (Millipore, Burlington, MA) at 4°C overnight. Incubated slides were 
washed with PBS 3 times for 3 mins. The slides were incubated with Cy3-conjugated IgG (Jackson 
ImmunoResearch Laboratories, West Grove, PA) and counterstained with DAPI. The stained 
slides were observed by using a fluorescent microscope (IX-81, Olympus, Center Valley, PA). 
Brightness (+20%) and contrast (-20%) of acquired fluorescence images were adjusted to improve 
visibility by using ImageJ software [154]. 
5.3 RESULS AND DISCUSSIONS 
5.3.1 Deconvolution based super-resolution ultrasound imaging 
In Figure 30, our developed imaging technique on a rabbit femoral artery is compared with 
conventional imaging technologies. The white rectangle represents the balloon injured area that is 
expected to develop the plaque with VV, and white arrows in all images indicate a big branch near 
the femoral artery that is used as the landmark to match the image plane among different 
modalities. CadenceTR harmonic contrast-enhanced imaging technique with using microbubbles 
operated by a commercial ultrasound scanner (Accuson Sequoia 512, SIEMENS, Mountain view, 
CA) shown in Figure 30(a) is a typical standard method in the clinic to evaluate microvasculature 
perfusion[138], [145], [155], [156]. However, this technique is limited in spatial resolution to 
identify and separate VV from the major vessel such as the femoral artery in this study. 
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Conventional B-mode image shown in Figure 30(b) only illustrates structural information of 
bifurcation area of the rabbit femoral artery and small vasculatures surrounding the fermoral artery 
cannot be identified due to limited spatial resolution. To amplify signal from the blood, power 
Doppler based temporal maximum intensity persistence (MIP) imaging technique (#’s of frames 
= 2,000) implemented in Verasonics system is used as shown in Figure 30(c).  
 
Figure 30. Comparison of several imaging modalities. (a) CadenceTR contrast enhanced imaging with 
microbubbles acquired by commercial ultrasound scanner (Sequoia 512, Siemens), (b) conventional B-
mode imaging, (c) temporal MIP vascular imaging, (d) proposed super resolution imaging of ROI. Same 
raw data is used to reconstruct images (b-d). White rectangle represents balloon injured area that the plaque 
is expected to be developed. White arrow indicates the same vessel branch that shows correlation of images 
acquired by two different ultrasound scanners. 
 
This method employs a tissue-rejection filter that suppresses stationary signal from tissue and 
extracts only signal from flowing microbubbles. However, its spatial resolution is still insufficient 
to clearly identify individual VV. The proposed super-resolution ultrasound imaging method 
implemented in Verasonics system shown in Figure 30(d) delineates detail of microvasculature 
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that is shown blurred in other imaging methods due to low spatial resolution that is mainly limited 
by diffraction limit of the operating frequency. 
To estimate maximum spatial resolution of our developed method, one of the finest vessels 
is chosen among discernable vasculatures in the Figure 31(a) (Selected region of Figure 30(d)). 
FWHM on lateral axis of the selected vessel is estimated to be 41 micron that is 5-fold smaller 
than wavelength as shown in Figure 31(b).  
 
 
Figure 31. Spatial resolution of proposed imaging method. (a) One of the finest vessels is chosen (white 
solid line) in the ROI, (b) Spatial profile of selected vessel. FWHM is estimated by 41 μm (<λ/5). 
 
Three sequential data-set are independently acquired using our super-resolution imaging 
sequence to verify repeatability of our proposed method. For three independent imaging sessions, 
bifurcation of femoral artery and the branched vessel indicated in white arrow in Figure 30 are 
identified as landmark to maintain the same imaging plane. Figure 32(a) depicts temporal MIP 
vascular imaging using the first data set of 2,000 frames, and Figure 32(b-d) represents 
reconstructed images from sequentially acquired the first, second and third data set (2,000 frames 
for each acquisition), respectively using our super-resolution imaging sequence. Note that Figure 
32(a) and (b) are reconstructed from same raw dataset. An obviously same major vessel is observed 
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at the center in all three reconstructed images to assure the same imaging plane among three 
imaging sessions. Some microvasculature in the background shown slightly different can be 
attributed to tilted imaging plane within three different imaging sessions. 
 
 
Figure 32. Repeatability of proposed method. (a) temporal MIP vascular network imaging using eigen-
decomposition method. (b-d) Super-resolution images using sequentially acquired three datasets (2,000 
frames per each image) from same region of interest. 
 
5.3.2 In vivo feasibility of the developed super-resolution technique in imaging vasa 
vasorum on a rabbit femoral artery 
Conventional B-mode imaging and super resolution imaging for vascular network of both 
side femoral artery, injured (experimental side) and contralateral non-injured side (control side), 
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are shown in Figure 33. In B-mode images (Figure 33(a, d)), adventitia area is represented in the 
yellow dotted line. Figure 33(b, c, e, f) show super-resolution images at diastole and systole on 
injured and the non-injured side, respectively. Each image at different stage of cardiac cycle is 
reconstructed from around 300 frames synchronized by STIC algorithm.  
 
Figure 33. B-mode image (a, d) and corresponding super-resolution perfusion image overlaid on the B-
mode image at diastole (b, e) and systole state (c, f). Top panel images are acquired from the injured side 
and bottom panel images are acquired from the non-injured side. Significant plaques are shown in the B-
mode image on the injured side. Yellow dotted line represents adventitia region and white arrows indicate 
vasa vasorum in the adventitia 
 
The abundance of VV in adventitia indicated by white arrows can be clearly observed on 
the injured-side in the super-resolution ultrasound imaging. Normalized VV density on the injured-
side is 0.027±0.004, which is approximately 3 times greater than non-injured side with 
0.010±0.001. Furthermore, apparent uneven surface on the vessel wall on the injured side is 
observed most likely due to plaque formation on the lumen wall. The vessel wall is overall 
thickened (injured: 410 μm vs non-injured: 220 μm) and the lumen diameter is decreased (injured: 
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1.1 mm vs non-injured: 1.4 mm) in injured side. These observations are more clearly confirmed 
by closely looking at blood flowing through VV from adventitia into media. 
VVs are more populated and believed to be infiltrated into the medial area of injured area, 
while less populated VV are found only in adventitial and connective tissue area in non-injured 
area. Atherosclerotic plaque formation and corresponding VV development is evidenced by 
histology of femoral artery section shown in Figure 34. The atherosclerotic lesions are 
characterized on injured side by neointimal proliferation, shown in Figure 34(b) by hematoxylin 
and eosin (H&E) stain and abnormally enriched VV development on adventitia, shown in Figure 
34(d) by immunofluorescence of von Willebrand Factor (vWF) stain. Pink solid line in Figure 
34(b) was drawn along endothelium in the tunica intima of the lumen. Total cholesterol level is 
measured 291 mg/dL that is approximately 3 times higher than standard range (< 100 mg/dL) due 
to feeding high-fat diet. 
 
Figure 34. Haematoxylin and eosin stained vessel on the injured side (a) and non-injured side (b). Thirty 
images acquired at ×40 magnification are stitched to reconstruct overall image of the vessel for (a) and (b). 
Significant plaque development is found in injured side (a). Vasa vasorum on adventitia in selected region 
was stained by anti-von Willebrand factor. A large number of vasa vasorums are found in adventitia on the 
injured side (c), but a few vasa vasorums are found in adventitia on the non-injured side (d). 
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5.4 CONCLUSION 
It has been shown that super-resolution ultrasound imaging technique has strong potential 
to extend the application of ultrasound imaging with unprecedented high spatial resolution [51], 
[52], [59], [157]. We further developed this imaging technology to overcome the limitation of the 
temporal resolution, which makes it capable of imaging of fast event. Our proposed super-
resolution imaging method successfully assesses VV density on the plaque in a rabbit femoral 
artery with enhanced temporal resolution as well as high spatial resolution. In our approach, 
deconvolution and STIC data acquisition were investigated to improve temporal resolution of US 
sub-diffraction imaging. It should be noted that deconvolution technique is known to be sensitive 
to noise as discussed in method section. Thresholding used in this study can successfully suppress 
noise, however it potentially also suppresses true signal when signal-to-noise ratio is relatively low 
for example in a fast plane-wave imaging. Therefore, more advanced adaptive noise reduction 
approach needs to be sought after to maximize signal-to-noise ratio while maintaining high 
temporal resolution in the future study. In addition, STIC data acquisition is generally used to 
collect and synchronize 3D data acquired from fast-moving fetal heart when using a relatively 
slow acquisition speed. It should be noted that there is an assumption in STIC acquisition; cardiac 
pulsation pattern over data acquisition period is stationary. With reduced total number of frames 
thanks to deconvolution, we were able to generate ten super-resolution images using 3,000 
acquired frames that can be collected within 6 seconds. Therefore, our approach has potential for 
free-hand scanning in the clinics because the acquisition time is significantly shorter than free-
hand data acquisition time of 3D-fetal echocardiography when using STIC acquisition in the 
standard clinical protocol that takes around 4 ~ 5 minutes on average[148], [158].  
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Since this study is concentrated on the technical development and in vivo feasibility 
demonstration, it is not intended to investigate any correlation between VV development and 
plaque stage with enough statistics, although this well-established rabbit model has been studied 
for a long time for various diseases in association with atherosclerotic plaques. Further extended 
study with an increased number of rabbits and time points is planned in the following study. In 
addition, the histology is limited for providing anatomically matched cross sections as a gold 
standard. An established anatomical imaging modality with high spatial resolution is necessary as 
a gold standard to provide more direct comparison, for example, ex-vivo microCT that enables to 
provide volumetric microvasculature information[159], [160]. 
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6.0  CONCLUSIONS 
The combined US and PA medical imaging system integrated with the developed 
innovative technologies provides superior signal and contrast to noise ratio that significantly 
improves imaging depth of PA imaging, which is one of critical barriers of current PA imaging for 
eventual translation. The developed system in this dissertation also achieves unprecedented high 
spatial resolution that opens door to further investigate microvasculature, which has been 
inherently limited in US enhanced contrast imaging due to the acoustic diffraction limit. The 
technology development involves a device that enhances laser light delivery scheme for PA 
imaging, novel dual-mode contrast agent for US/PA imaging as well as photo-stable small 
molecule dye for PA imaging, and novel super resolution imaging technique for US imaging.  
Initial efforts in PA imaging was based on that with conventional laser light delivery 
scheme a large portion of incident laser energy is lost due to strong reflection on the skin surface. 
Such light loss directly led to a reduction of PA signal amplitude, thus limiting imaging depth. In 
this work, the hemisphere-shaped device was developed to recover incident light loss. The device 
improved PA signal intensity by approximately 30% in vivo that is close to the expected light loss 
from the skin when using the traditional laser delivery scheme. The device was evaluated in mouse 
cancer imaging in vivo. In the next effort in PA imaging, a novel exogenous PA contrast agents 
that utilizes vaporization, being a more efficient PA mechanism than traditionally used thermal 
expansion mechanism were developed. In this work, the underlying mechanism of the optically-
triggered vaporization process was investigated by concurrent acoustic and optical measurements. 
The finding based on these observations is highly expected to foster further optimal design 
parameters of optically-triggered phase transition droplets. In addition, novel near-infrared PA 
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contrast agents, QR-4PyC4 and QR-G2-COOH, based on quaterrylene structure are strategically 
designed as strong candidates of reliable PA agents for a long-term imaging. QR-4PyC4 is a 
promising candidate as a universal, sensitive, and reliable PA agent and QR-G2-COOH has 
potential as a nano-system with its high structural flexibility for PA molecular imaging. The 
following work was to achieve unprecedented spatial resolution of US imaging beyond the 
acoustic diffraction limit using innovative microbubble localization technique, so called super-
resolution US imaging. In this study, a deconvolution-based microbubble localization technique 
combined with spatio-temporal interframe correlation based data acquisition technique was 
developed to not only overcome the traditional physical barrier in the spatial resolution but also 
improve the temporal resolution that is major shortcoming of typical localization technique. The 
in vivo feasibility of the developed technique was evaluated using the rabbit atherosclerotic plaque 
model. The spatial resolution was improved by up to 5 times the acoustic diffraction limit with 
significantly shortened data acquisition time of six seconds or less.  
For the long-term goal of the research program, we envision that the developed novel 
imaging technologies will provide a strong motivation and a key technical foundation to build a 
US and PA multi-modal imaging system which can be used in pre-clinical and clinical research 
and for extensive investigations for further translation from benchtop to bedside. 
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APPENDIX B 
THEORETICAL ANALYSIS OF VAPORIZATION CONDITION 
B.1 ESTIMATED VAPORIZATION TEMPERATURE THRESHOLD BASED ON 
THE LAPLACE PRESSURE 
For small droplets of perfluoropentane stabilized by bovine serum albumin shells, the 
developed Laplace pressure may increase boiling temperature. The Laplace pressure is caused by 
surface tension at the interface between droplet liquid and bulk liquid that can be expressed by 
∆𝑃𝑃 = 𝑃𝑃𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 − 𝑃𝑃𝑜𝑜𝑜𝑜𝑡𝑡𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 2𝜎𝜎𝑟𝑟𝑖𝑖𝑟𝑟𝑜𝑜𝑑𝑑𝑙𝑙𝑖𝑖𝑡𝑡 
where Pinside is the pressure inside a droplet, Poutside is the pressure outside a droplet (standard 
atmosphere pressure), σ is surface tension and rdroplet is radius of droplet.  
 
Figure 35. Vaporization threshold temperature according to droplet diameter 
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The vaporization threshold temperature depending on droplet size can be calculated by using 
Antoine equation given as 
log10 𝑃𝑃 = 𝐴𝐴 − � 𝐵𝐵𝑇𝑇 + 𝐶𝐶� 
where A,B, and C are the constants for the perfluoropentane were reported in previous [76]. Here 
we used Poutside = 1 atm, σ = 75 mN/m, A = 6.88375, B = 961.192, and C = 75512.4 
B.2 ESTIMATED EXPANSION RATIO OF DROPLET 
Calculation of Laplace pressure of vaporized droplet at the interface between bubble and 
bulk liquid can be represented by 
∆𝑃𝑃 = 𝑃𝑃𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 − 𝑃𝑃𝑜𝑜𝑜𝑜𝑡𝑡𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 2𝜎𝜎𝑟𝑟𝑏𝑏𝑜𝑜𝑏𝑏𝑏𝑏𝑙𝑙𝑖𝑖 
Ideal gas law can be applied to the vaporized droplet, that is bubble.  
𝑃𝑃𝑏𝑏𝑜𝑜𝑏𝑏𝑏𝑏𝑙𝑙𝑖𝑖𝑉𝑉 = 𝑛𝑛𝑅𝑅𝑇𝑇 
where Pbubble is the pressure inside the bubble, V is the volume of the bubble, n is the amount of 
substance of the gas, R is the Boltzmann constant, and T is the absolute of the bubble. Here, volume 
can be expressed by radius if shell thickness can be ignored, 
𝑉𝑉 = 43𝜋𝜋𝑟𝑟𝑏𝑏𝑜𝑜𝑏𝑏𝑏𝑏𝑙𝑙𝑖𝑖3 
and n can be calculated by below equation if we assume that the droplet is fully vaporized. 
𝑛𝑛 = 43𝜋𝜋𝑟𝑟𝑖𝑖𝑟𝑟𝑜𝑜𝑑𝑑𝑙𝑙𝑖𝑖𝑡𝑡3 × 𝐷𝐷𝑛𝑛𝑛𝑛𝑛𝑛𝑖𝑖𝑡𝑡𝑑𝑑𝑃𝑃𝑃𝑃𝑃𝑃−𝑙𝑙𝑖𝑖𝑙𝑙𝑜𝑜𝑖𝑖𝑖𝑖 × 1𝑀𝑀𝑛𝑛𝑠𝑠𝑉𝑉𝑟𝑟𝑀𝑀𝑛𝑛𝑖𝑖𝑔𝑔ℎ𝑡𝑡𝑃𝑃𝑃𝑃𝑃𝑃 
All these equations can be combined into one equation, it can be expressed by 
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𝑅𝑅𝑖𝑖𝑟𝑟𝑜𝑜𝑑𝑑𝑙𝑙𝑖𝑖𝑡𝑡 = �𝑃𝑃𝑎𝑎𝑡𝑡𝑎𝑎𝛼𝛼 𝑅𝑅𝑏𝑏𝑜𝑜𝑏𝑏𝑏𝑏𝑙𝑙𝑖𝑖3 + 2𝜎𝜎𝛼𝛼 𝑅𝑅𝑏𝑏𝑜𝑜𝑏𝑏𝑏𝑏𝑙𝑙𝑖𝑖2�13 
where α is constant can be expressed by 
𝛼𝛼 = 𝑅𝑅𝑇𝑇𝐷𝐷𝑛𝑛𝑛𝑛𝑛𝑛𝑖𝑖𝑡𝑡𝑑𝑑𝑃𝑃𝑃𝑃𝑃𝑃−𝑙𝑙𝑖𝑖𝑙𝑙𝑜𝑜𝑖𝑖𝑖𝑖
𝑀𝑀𝑛𝑛𝑠𝑠𝑉𝑉𝑟𝑟𝑀𝑀𝑛𝑛𝑖𝑖𝑔𝑔ℎ𝑡𝑡𝑃𝑃𝑃𝑃𝑃𝑃
 
The molar weight of perfluoropentane is 288.04 g/mol and the density of perfluoropentane is 
1.59X106g/m3 (at 37°C).  
 
Figure 36. Theoretical expansion ratio vs droplet diameter 
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APPENDIX C 
FPGA DESIGN OF TIMING CONTROLLER IN CHAPTER 3 
C.1 SYSTEM DESIGN RESTRICTIONS 
 
Figure 37. Timing diagram for the laser system and the high-speed camera 
- Requirements for laser system (OPOtek Vibrant 532HE) - Figure 35 
o Master clock for flash lamp operation should have 10Hz clock with 10% tolerance. It 
cannot be changed once flashlamp starts. 
o Delay between “flashlamp sync out” and “Q-Switch external trigger-in” should be ≥ 
220us. (To get max power, it should be set as 220 μs). Therefore, signals of flashlamp-
out, Q-switch in and Q-switch out is automatically determined depending on flashlamp-
out timing to maintain stable and the highest laser power.  
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o Initialization time of “8 secs” for warm-up should be required to avoid transient thermal 
effect for Nd:YAG rod when flashlamp start from idle state. 
- Requirements for the high-speed camera (UPMC cam, Cordin 512) – Figure 35 
o There are only “Trigger out signal” to other systems and no “Trigger-in” for 
synchronization purpose. 
o Trigger out signal from the camera can be advanced up to 15 ms from camera recording 
start. This delay has jitter error due to turbine mechanism. 
 
- Issue and solution 
o In ideal case, synchronization between flashlamp clock (SLOW, 10 Hz) and high-speed 
camera system (FAST, 5-25 MHz) is required, however the master clock cannot be 
shared due to system design restriction. Therefore, handshaking communication is 
necessary between two asynchronous systems. Common approach is triggering from 
the fast system (the camera) to the slow system (the laser), however, the laser system 
has to wait 8 secs for warm-up after initial input of flashlamp-in clock while the camera 
trigger signal can be advanced the only 15 ms. Therefore, the perfect synchronization 
is not available for this case.  
o Solution: Therefore, there should be some missing case. To maximize success rate, 
utilization of 10 % tolerance of flashlamp-in (9-11 Hz, therefore, adjusting the laser 
flashlamep clock adaptively) could have potential to synchronize between two systems 
with success rate of 20-31.3%. (depending on parameters) In this case, custom-made 
central timing controller to provide adaptive master clock for the laser system is 
demanded to manage trigger signals of each system. 
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Caution! Using external trigger signals for laser operation may give electrical damage 
(Especially clock control) to the laser system, so, all parameters should be carefully 
chosen after confirmation of all related signals timing before connecting to the laser 
system  
C.2 BLOCK DIAGRAM 
 
Figure 38. Block diagram of the interface between FPGA, the high-speed camera, and the laser system. 
 
Figure 38 shows the block diagram of interface between FPGA, camera, and laser system. 
Required input electronic characteristic of synchronization for laser system is shown in below 
Figure as a reference. All systems are connected by using shielded-BNC cable with 50 ohm 
impedance. For this setup, the FPGA timing controller generates master clock for the laser system 
flash lamp and a trigger signal for Q-switch. The laser system should be configured to use external 
clocks. Using internal clock for Q-switch is not recommended while the internal clock generation 
mechanism is black box.  
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Figure 39. Timing diagram of flash-lamp and Q-switch of the laser system 
C.3 TIMING DIAGRAM 
As explained in the section B.1, the only flashlamp-in signal can be adjustable within 10 % 
tolerance. All other signals (Q-Switch in/out) will be determined depending on flashlamp-in signal. 
First, flash lamp master clock is set as 10 Hz, therefore, period duration of flash lamp clock is 100 
ms. This is the maximum time duration for each event. While the master clock duration can be 
adjustable between 90 – 110ms, the systems can be synchronized only when the camera trigger 
signal come into between 75 – 95 ms indicated in the red zone. If the camera trigger arrives other 
than the red zone, the timing controller ignore the camera trigger signal and does not generate Q-
switch trigger signal. To increase success rate, flash lamp master clock can be chosen as 9 Hz and 
corresponding period duration is 110 ms. In this case, success time zone is 75 – 109.5ms, therefore, 
success rate can be increased up to 31.3 % (34.5 ms / 110 ms). Delay between flashlamp-out and 
laser excitation may be around 220-230 µs. Around 250 µs is added as a margin. However, the 
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parameters for this setup is not recommended due to possibility of unexpected system burden. For 
all experiments, all parameters should be carefully chosen with sufficient margin to minimize 
malfunction of the laser system. 
 
Figure 40. Scenarios for capture success and failure 
C.4 STATE MACHINE DESIGNS AND IMPLEMENTAIONS 
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The timing controller written in VHDL (See Appendix. B. 5) is implemented into the FPGA board 
connected with custom-made input/output circuit as shown in Figure. Below are specification of 
the FPGA board and development environment (Figure 41).  
- FPGA: Xilinx Spartan 6 XC6LX16-CS324 (Digilent Nexsys3 FPGA starter kit) 
- Digital system description language: VHDL 
- Synthesizer: Xilinx XST 
-  
 
Figure 41. Developed timing controller using FPGA board with add-on input/output circuit 
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C.5 VHDL HARDWARE DESCRIPTION FOR STATE MACHINE 
---------------------------------------------------------------------------------- 
-- University of Pittsburgh 
-- Jaesok Yu 
--  
-- Create Date:    15:12:22 12/28/2013  
-- Design Name: Timing controller between the laser system and the camera 
-- Module Name:    m_timing_top - Behavioral  
-- 
-- 
-- Revision 0.01 
-- 
---------------------------------------------------------------------------------- 
library IEEE; 
use IEEE.STD_LOGIC_1164.ALL; 
use IEEE.STD_LOGIC_ARITH.ALL; 
use IEEE.STD_LOGIC_UNSIGNED.ALL; 
 
-- Uncomment the following library declaration if using 
-- arithmetic functions with Signed or Unsigned values 
--use IEEE.NUMERIC_STD.ALL; 
 
-- Uncomment the following library declaration if instantiating 
-- any Xilinx primitives in this code. 
--library UNISIM; 
--use UNISIM.VComponents.all; 
 
entity m_timing_top is 
   Port ( SW : in  STD_LOGIC_VECTOR (7 downto 0); 
           BTN : in  STD_LOGIC_VECTOR (4 downto 0); 
           CLK : in  STD_LOGIC; 
           DATA : out STD_LOGIC_VECTOR (1 downto 0); 
           DATA_IN : in STD_LOGIC_VECTOR (0 downto 0); 
           LED : out  STD_LOGIC_VECTOR (7 downto 0) 
     ); 
end m_timing_top; 
 
architecture Behavioral of m_timing_top is 
 
type type_delay_state is (st_init, st_active, st_wait); 
signal st_state : type_delay_state; 
signal st_state_data_in : type_delay_state; 
signal s_clk : std_logic; 
signal s_reset: std_logic; 
signal s_delay_start : std_logic; 
signal s_delay_start_data_in : std_logic; 
signal s_tc_pulse  : std_logic; 
signal s_tc_wait: std_logic; 
signal s_pulse_delay: std_logic_vector(27 downto 0); 
signal s_wait_delay: std_logic_vector(27 downto 0); 
--signal c_pulse_delay : std_logic_vector(27 downto 0); -- 200ms/Laser Setup : 10Hz 
constant c_pulse_delay : std_logic_vector(27 downto 0) := X"1312D00"; -- 200ms/Laser Setup : 10Hz 
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--constant c_pulse_delay : std_logic_vector(27 downto 0)   := X"0E4E1C0"; -- 150ms/Laser Setup : 10Hz 
--constant c_pulse_delay : std_logic_vector(27 downto 0)   := X"0989680"; -- 100ms/Laser Setup : 10Hz 
--constant c_pulse_delay : std_logic_vector(27 downto 0)   := X"04C4B40"; -- 50ms/Laser Setup : 10Hz 
constant c_wait_delay : std_logic_vector(27 downto 0) :=  X"5F5E100"; -- 1S/ Laser Setup :10Hz 
 
begin 
-- CLK & RESET 
-- CLK : 100MHz, 10ns 
-- BTN(4) : Reset 
 s_clk  <= CLK; 
 s_reset <= BTN(4); -- Active high reset 
 s_delay_start <= BTN(0) or s_delay_start_data_in; -- Delay Start 
 s_delay_start_data_in <= '1' when st_state_data_in = st_active else '0'; 
  
  
 -- Pulse Duration Counter 
 PulseDuration_Counter : process(s_clk, s_reset) 
 begin 
 if s_reset = '1' then 
  s_pulse_delay <= (others=>'0'); 
 elsif rising_edge(s_clk) then 
  if st_state = st_active then 
   s_pulse_delay <= s_pulse_delay + '1'; 
  else 
   s_pulse_delay <= (others=>'0'); 
  end if; 
 end if; 
 end process; 
 s_tc_pulse <= '1' when s_pulse_delay = c_pulse_delay else '0'; 
  
  
 -- Wait Duration Counter 
 WaitDuration_Counter : process(s_clk, s_reset) 
 begin 
 if s_reset = '1' then 
  s_wait_delay <= (others=>'0'); 
 elsif rising_edge(s_clk) then 
  if st_state = st_wait and s_tc_wait = '0' then 
   s_wait_delay <= s_wait_delay + '1'; 
  elsif st_state = st_wait and s_tc_wait = '1' then 
   s_wait_delay <= s_wait_delay;      
  elsif st_state = st_init then 
   s_wait_delay <= (others=>'0'); 
  else 
   s_wait_delay <= s_wait_delay;    
  end if; 
 end if; 
 end process; 
 s_tc_wait <= '1' when s_wait_delay = c_wait_delay else '0'; 
  
  
  
 -- Main State Machine 
 MainStateMachine : process(s_clk, s_reset) 
 begin 
 if s_reset = '1' then 
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  st_state <= st_init; 
   
 elsif rising_edge(s_clk) then 
  case st_state is 
   when st_init => 
    if s_delay_start = '1' then 
     st_state <= st_active; 
    else 
     st_state <= st_init; 
    end if; 
 
   when st_active => 
-- Burst Case 
--    if s_tc_pulse = '1' and s_delay_start = '0' then 
-- Normal Case 
    if s_tc_pulse = '1' then  
     st_state <= st_wait; 
    else 
     st_state <= st_active; 
    end if; 
 
   when st_wait => 
    if s_delay_start = '1' or s_tc_wait = '0' then 
     st_state <= st_wait; 
    else 
     st_state <= st_init; 
    end if; 
   end case; 
  end if; 
  end process; 
 
 -- Trigger in 
 GenerateTriggerInSignal : process(s_clk, s_reset) 
 begin 
 if s_reset = '1' then 
  st_state_data_in <= st_init; 
   
 elsif rising_edge(s_clk) then 
  case st_state_data_in is 
   when st_init => 
    if DATA_IN(0) = '1' then 
     st_state_data_in <= st_active; 
    else 
     st_state_data_in <= st_init; 
    end if; 
 
   when st_active => 
    st_state_data_in <= st_wait; 
--    if s_tc_pulse = '1' then 
--     st_state_data_in <= st_wait; 
--    else 
--     st_state_data_in <= st_active; 
--    end if; 
 
   when st_wait => 
    if DATA_IN(0) = '1' then 
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     st_state_data_in <= st_wait; 
    else 
     st_state_data_in <= st_init; 
    end if; 
   end case; 
  end if; 
  end process; 
 
-- Trigger Signal Generator 
 DATA(0) <= '0' when st_state = st_active else '1'; 
 DATA(1) <= '1' when st_state = st_active else '0'; 
 
-- LED Pins 
 LED(0)  <= DATA_IN(0) or BTN(0); -- R 
 LED(1)  <= BTN(1); -- D 
-- LED(2)  <= BTN(2); -- L  
-- LED(3)  <= BTN(3); -- U 
 LED(2)  <= '1' when (st_state_data_in = st_init) or (BTN(2) = '1') else '0'; -- UBTN(1); -- D  
 LED(3)  <= '1' when st_state_data_in = st_active else '0'; -- U 
 LED(4) <= BTN(4); -- RESET 
 LED(5) <= '1' when st_state = st_init else '0'; -- Active 
 LED(6) <= '1' when st_state = st_active else '0'; -- Active; 
 LED(7) <= '1' when st_state = st_wait else '0'; -- Active;  
end Behavioral;  
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